group_name,group_level,strata_name,strata_level,variable,variable_level,variable_type,estimate_type,estimate,cdm_name
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,number subjects,NA,NA,count,15206,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,number records,NA,NA,count,15206,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age,NA,numeric,median,59,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age,NA,numeric,q25,47,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age,NA,numeric,q75,69,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,future_observation,NA,numeric,median,274,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,future_observation,NA,numeric,q25,122,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,future_observation,NA,numeric,q75,436,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,prior_history,NA,numeric,median,1001,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,prior_history,NA,numeric,q25,560,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,prior_history,NA,numeric,q75,1486,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,cohort_end_date,NA,date,median,2021-11-01,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,cohort_end_date,NA,date,q25,2021-04-14,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,cohort_end_date,NA,date,q75,2022-04-04,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,cohort_start_date,NA,date,median,2021-05-06,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,cohort_start_date,NA,date,q25,2020-12-04,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,cohort_start_date,NA,date,q75,2021-10-22,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,4376,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,28.7781139024069,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,antibacterials_systemic_m365_to_0,NA,binary,count,7591,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,antibacterials_systemic_m365_to_0,NA,binary,%,49.9210837827173,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,antidepressants_m365_to_0,NA,binary,count,5314,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,antidepressants_m365_to_0,NA,binary,%,34.9467315533342,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,antiepileptics_m365_to_0,NA,binary,count,3392,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,antiepileptics_m365_to_0,NA,binary,%,22.3069840852295,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,11095,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,72.9646192292516,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,antineoplastic_agents_m365_to_0,NA,binary,count,15206,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,antineoplastic_agents_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,antithrombotics_m365_to_0,NA,binary,count,2075,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,antithrombotics_m365_to_0,NA,binary,%,13.6459292384585,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,anxiety_minf_to_0,NA,binary,count,4691,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,anxiety_minf_to_0,NA,binary,%,30.8496646060765,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,asthma_minf_to_0,NA,binary,count,2224,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,asthma_minf_to_0,NA,binary,%,14.6258056030514,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,beta_blocking_agents_m365_to_0,NA,binary,count,3154,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,beta_blocking_agents_m365_to_0,NA,binary,%,20.7418124424569,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,calicum_channel_blockers_m365_to_0,NA,binary,count,2443,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,calicum_channel_blockers_m365_to_0,NA,binary,%,16.0660265684598,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,chronic_kidney_disease_minf_to_0,NA,binary,count,1496,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,chronic_kidney_disease_minf_to_0,NA,binary,%,9.83822175457057,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,chronic_liver_disease_minf_to_0,NA,binary,count,1496,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,chronic_liver_disease_minf_to_0,NA,binary,%,9.83822175457057,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,copd_minf_to_0,NA,binary,count,1540,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,copd_minf_to_0,NA,binary,%,10.1275812179403,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,covid_minf_to_0,NA,binary,count,3826,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,covid_minf_to_0,NA,binary,%,25.1611206102854,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,dementia_minf_to_0,NA,binary,count,213,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,dementia_minf_to_0,NA,binary,%,1.40076285676707,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,depressive_disorder_minf_to_0,NA,binary,count,3853,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,depressive_disorder_minf_to_0,NA,binary,%,25.3386820991714,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,diabetes_minf_to_0,NA,binary,count,2899,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,diabetes_minf_to_0,NA,binary,%,19.0648428252006,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,diuretics_m365_to_0,NA,binary,count,2952,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,diuretics_m365_to_0,NA,binary,%,19.4133894515323,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,drugs_acid_related_disorder_m365_to_0,NA,binary,count,4438,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,drugs_acid_related_disorder_m365_to_0,NA,binary,%,29.1858476917006,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,3832,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,25.2005787189267,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,drugs_used_in_diabetes_m365_to_0,NA,binary,count,2263,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,drugs_used_in_diabetes_m365_to_0,NA,binary,%,14.88228330922,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,gerd_minf_to_0,NA,binary,count,4415,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,gerd_minf_to_0,NA,binary,%,29.0345916085756,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,heart_failure_minf_to_0,NA,binary,count,970,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,heart_failure_minf_to_0,NA,binary,%,6.37906089701434,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,hiv_minf_to_0,NA,binary,count,22,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,hiv_minf_to_0,NA,binary,%,0.144679731684861,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,944,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,6.20807575956859,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,hypertension_minf_to_0,NA,binary,count,7660,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,hypertension_minf_to_0,NA,binary,%,50.3748520320926,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,hypothyroidism_minf_to_0,NA,binary,count,2964,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,hypothyroidism_minf_to_0,NA,binary,%,19.4923056688149,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,immunosupressants_m365_to_0,NA,binary,count,15206,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,immunosupressants_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,infertility_minf_to_0,NA,binary,count,100,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,infertility_minf_to_0,NA,binary,%,0.657635144022097,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,inflammatory_bowel_disease_minf_to_0,NA,binary,count,699,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,inflammatory_bowel_disease_minf_to_0,NA,binary,%,4.59686965671446,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,lipid_modifying_agents_m365_to_0,NA,binary,count,4802,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,lipid_modifying_agents_m365_to_0,NA,binary,%,31.5796396159411,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,malaria_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,malaria_minf_to_0,NA,binary,%,0.00657635144022097,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,malignant_neoplastic_disease_minf_to_0,NA,binary,count,2536,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,malignant_neoplastic_disease_minf_to_0,NA,binary,%,16.6776272524004,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,myocardial_infarction_minf_to_0,NA,binary,count,281,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,myocardial_infarction_minf_to_0,NA,binary,%,1.84795475470209,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,opioids_m365_to_0,NA,binary,count,4319,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,opioids_m365_to_0,NA,binary,%,28.4032618703143,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,osteoporosis_minf_to_0,NA,binary,count,1853,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,osteoporosis_minf_to_0,NA,binary,%,12.1859792187294,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,pneumonia_minf_to_0,NA,binary,count,1175,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,pneumonia_minf_to_0,NA,binary,%,7.72721294225963,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,psycholeptics_m365_to_0,NA,binary,count,4420,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,psycholeptics_m365_to_0,NA,binary,%,29.0674733657767,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,psychostimulants_m365_to_0,NA,binary,count,503,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,psychostimulants_m365_to_0,NA,binary,%,3.30790477443115,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,rheumatoid_arthritis_minf_to_0,NA,binary,count,7299,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,rheumatoid_arthritis_minf_to_0,NA,binary,%,48.0007891621728,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,stroke_minf_to_0,NA,binary,count,384,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,stroke_minf_to_0,NA,binary,%,2.52531895304485,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,venous_thromboembolism_minf_to_0,NA,binary,count,509,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,venous_thromboembolism_minf_to_0,NA,binary,%,3.34736288307247,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age_group,0 to 19,categorical,count,511,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age_group,0 to 19,categorical,%,3.36051558595291,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age_group,20 to 39,categorical,count,1938,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age_group,20 to 39,categorical,%,12.7449690911482,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age_group,40 to 59,categorical,count,5344,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age_group,40 to 59,categorical,%,35.1440220965408,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age_group,60 to 79,categorical,count,6232,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age_group,60 to 79,categorical,%,40.9838221754571,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age_group,80 to 150,categorical,count,1181,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,age_group,80 to 150,categorical,%,7.76667105090096,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,indication,covid,categorical,count,96,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,indication,covid,categorical,%,0.631329738261213,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,indication,malaria,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,indication,malaria,categorical,%,0.00657635144022097,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,indication,multiple,categorical,count,96,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,indication,multiple,categorical,%,0.631329738261213,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,indication,none,categorical,count,7803,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,indication,none,categorical,%,51.3152702880442,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,indication,rheumatoid_arthritis,categorical,count,7210,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,indication,rheumatoid_arthritis,categorical,%,47.4154938839932,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,sex,Female,categorical,count,10590,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,sex,Female,categorical,%,69.64356175194,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,sex,Male,categorical,count,4616,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,sex,Male,categorical,%,30.35643824806,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,window,after_fda_retraction,categorical,count,15206,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,window,after_fda_retraction,categorical,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,window,before_pandemic,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,window,before_pandemic,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,window,during_hcq_use_for_covid,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,after_fda_retraction,window,during_hcq_use_for_covid,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,number subjects,NA,NA,count,18770,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,number records,NA,NA,count,18770,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age,NA,numeric,median,59,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age,NA,numeric,q25,48,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age,NA,numeric,q75,68,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,future_observation,NA,numeric,median,793,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,future_observation,NA,numeric,q25,293,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,future_observation,NA,numeric,q75,1092,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,prior_history,NA,numeric,median,730,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,prior_history,NA,numeric,q25,730,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,prior_history,NA,numeric,q75,874,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,cohort_end_date,NA,date,median,2019-09-26,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,cohort_end_date,NA,date,q25,2019-05-05,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,cohort_end_date,NA,date,q75,2020-03-10,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,cohort_start_date,NA,date,median,2019-03-13,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,cohort_start_date,NA,date,q25,2019-01-01,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,cohort_start_date,NA,date,q75,2019-08-15,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,5676,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,30.2397442727757,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,antibacterials_systemic_m365_to_0,NA,binary,count,10605,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,antibacterials_systemic_m365_to_0,NA,binary,%,56.4997336174747,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,antidepressants_m365_to_0,NA,binary,count,5372,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,antidepressants_m365_to_0,NA,binary,%,28.6201385189132,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,antiepileptics_m365_to_0,NA,binary,count,3814,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,antiepileptics_m365_to_0,NA,binary,%,20.3196590303676,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,13890,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,74.0010655301012,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,antineoplastic_agents_m365_to_0,NA,binary,count,18770,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,antineoplastic_agents_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,antithrombotics_m365_to_0,NA,binary,count,2246,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,antithrombotics_m365_to_0,NA,binary,%,11.9659030367608,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,anxiety_minf_to_0,NA,binary,count,4249,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,anxiety_minf_to_0,NA,binary,%,22.6371870005328,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,asthma_minf_to_0,NA,binary,count,2458,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,asthma_minf_to_0,NA,binary,%,13.0953649440597,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,beta_blocking_agents_m365_to_0,NA,binary,count,3860,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,beta_blocking_agents_m365_to_0,NA,binary,%,20.5647309536494,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,calicum_channel_blockers_m365_to_0,NA,binary,count,2779,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,calicum_channel_blockers_m365_to_0,NA,binary,%,14.8055407565264,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,chronic_kidney_disease_minf_to_0,NA,binary,count,1449,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,chronic_kidney_disease_minf_to_0,NA,binary,%,7.71976558337773,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,chronic_liver_disease_minf_to_0,NA,binary,count,1449,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,chronic_liver_disease_minf_to_0,NA,binary,%,7.71976558337773,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,copd_minf_to_0,NA,binary,count,1515,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,copd_minf_to_0,NA,binary,%,8.0713905167821,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,covid_minf_to_0,NA,binary,count,1129,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,covid_minf_to_0,NA,binary,%,6.01491742141716,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,dementia_minf_to_0,NA,binary,count,245,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,dementia_minf_to_0,NA,binary,%,1.30527437400107,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,depressive_disorder_minf_to_0,NA,binary,count,3671,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,depressive_disorder_minf_to_0,NA,binary,%,19.5578050079915,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,diabetes_minf_to_0,NA,binary,count,3184,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,diabetes_minf_to_0,NA,binary,%,16.9632392115077,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,diuretics_m365_to_0,NA,binary,count,3508,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,diuretics_m365_to_0,NA,binary,%,18.6893979754928,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,drugs_acid_related_disorder_m365_to_0,NA,binary,count,5287,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,drugs_acid_related_disorder_m365_to_0,NA,binary,%,28.1672882258924,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,4705,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,25.0665956313266,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,drugs_used_in_diabetes_m365_to_0,NA,binary,count,2556,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,drugs_used_in_diabetes_m365_to_0,NA,binary,%,13.6174746936601,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,gerd_minf_to_0,NA,binary,count,4643,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,gerd_minf_to_0,NA,binary,%,24.7362812999467,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,heart_failure_minf_to_0,NA,binary,count,924,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,heart_failure_minf_to_0,NA,binary,%,4.92274906766116,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,hiv_minf_to_0,NA,binary,count,26,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,hiv_minf_to_0,NA,binary,%,0.138518913159297,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,1108,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,5.90303676078849,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,hypertension_minf_to_0,NA,binary,count,9293,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,hypertension_minf_to_0,NA,binary,%,49.5098561534363,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,hypothyroidism_minf_to_0,NA,binary,count,3381,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,hypothyroidism_minf_to_0,NA,binary,%,18.0127863612147,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,immunosupressants_m365_to_0,NA,binary,count,18770,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,immunosupressants_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,infertility_minf_to_0,NA,binary,count,86,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,infertility_minf_to_0,NA,binary,%,0.458177943526905,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,inflammatory_bowel_disease_minf_to_0,NA,binary,count,813,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,inflammatory_bowel_disease_minf_to_0,NA,binary,%,4.33137986148109,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,lipid_modifying_agents_m365_to_0,NA,binary,count,5688,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,lipid_modifying_agents_m365_to_0,NA,binary,%,30.3036760788492,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,malaria_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,malaria_minf_to_0,NA,binary,%,0.0159829515183804,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,malignant_neoplastic_disease_minf_to_0,NA,binary,count,2695,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,malignant_neoplastic_disease_minf_to_0,NA,binary,%,14.3580181140117,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,myocardial_infarction_minf_to_0,NA,binary,count,297,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,myocardial_infarction_minf_to_0,NA,binary,%,1.58231220031966,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,opioids_m365_to_0,NA,binary,count,5915,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,opioids_m365_to_0,NA,binary,%,31.51305274374,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,osteoporosis_minf_to_0,NA,binary,count,2151,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,osteoporosis_minf_to_0,NA,binary,%,11.4597762386787,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,pneumonia_minf_to_0,NA,binary,count,1284,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,pneumonia_minf_to_0,NA,binary,%,6.84070324986681,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,psycholeptics_m365_to_0,NA,binary,count,4899,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,psycholeptics_m365_to_0,NA,binary,%,26.1001598295152,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,psychostimulants_m365_to_0,NA,binary,count,473,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,psychostimulants_m365_to_0,NA,binary,%,2.51997868939798,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,rheumatoid_arthritis_minf_to_0,NA,binary,count,10024,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,rheumatoid_arthritis_minf_to_0,NA,binary,%,53.404368673415,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,stroke_minf_to_0,NA,binary,count,379,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,stroke_minf_to_0,NA,binary,%,2.01917954182206,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,venous_thromboembolism_minf_to_0,NA,binary,count,521,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,venous_thromboembolism_minf_to_0,NA,binary,%,2.77570591369206,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age_group,0 to 19,categorical,count,663,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age_group,0 to 19,categorical,%,3.53223228556207,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age_group,20 to 39,categorical,count,2077,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age_group,20 to 39,categorical,%,11.0655301012254,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age_group,40 to 59,categorical,count,7065,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age_group,40 to 59,categorical,%,37.6398508257858,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age_group,60 to 79,categorical,count,7471,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age_group,60 to 79,categorical,%,39.8028769312733,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age_group,80 to 150,categorical,count,1494,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,age_group,80 to 150,categorical,%,7.95950985615344,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,indication,covid,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,indication,covid,categorical,%,0.0053276505061268,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,indication,multiple,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,indication,multiple,categorical,%,0.0159829515183804,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,indication,none,categorical,count,8740,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,indication,none,categorical,%,46.5636654235482,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,indication,rheumatoid_arthritis,categorical,count,10026,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,indication,rheumatoid_arthritis,categorical,%,53.4150239744273,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,indication,malaria,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,indication,malaria,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,sex,Female,categorical,count,12892,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,sex,Female,categorical,%,68.6840703249867,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,sex,Male,categorical,count,5878,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,sex,Male,categorical,%,31.3159296750133,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,window,before_pandemic,categorical,count,18770,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,window,before_pandemic,categorical,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,window,after_fda_retraction,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,window,after_fda_retraction,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,window,during_hcq_use_for_covid,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,before_pandemic,window,during_hcq_use_for_covid,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,number subjects,NA,NA,count,3521,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,number records,NA,NA,count,3521,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age,NA,numeric,median,58,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age,NA,numeric,q25,47,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age,NA,numeric,q75,67,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,future_observation,NA,numeric,median,680,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,future_observation,NA,numeric,q25,293,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,future_observation,NA,numeric,q75,752,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,prior_history,NA,numeric,median,1092,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,prior_history,NA,numeric,q25,514,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,prior_history,NA,numeric,q75,1181,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,cohort_end_date,NA,date,median,2020-07-23,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,cohort_end_date,NA,date,q25,2020-05-17,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,cohort_end_date,NA,date,q75,2020-12-25,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,cohort_start_date,NA,date,median,2020-03-27,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,cohort_start_date,NA,date,q25,2020-02-28,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,cohort_start_date,NA,date,q75,2020-05-05,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,1021,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,28.9974439079807,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,antibacterials_systemic_m365_to_0,NA,binary,count,1915,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,antibacterials_systemic_m365_to_0,NA,binary,%,54.3879579664868,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,antidepressants_m365_to_0,NA,binary,count,1036,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,antidepressants_m365_to_0,NA,binary,%,29.4234592445328,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,antiepileptics_m365_to_0,NA,binary,count,729,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,antiepileptics_m365_to_0,NA,binary,%,20.7043453564328,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,2606,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,74.0130644703209,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,antineoplastic_agents_m365_to_0,NA,binary,count,3521,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,antineoplastic_agents_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,antithrombotics_m365_to_0,NA,binary,count,381,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,antithrombotics_m365_to_0,NA,binary,%,10.8207895484237,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,anxiety_minf_to_0,NA,binary,count,913,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,anxiety_minf_to_0,NA,binary,%,25.9301334848055,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,asthma_minf_to_0,NA,binary,count,485,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,asthma_minf_to_0,NA,binary,%,13.7744958818517,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,beta_blocking_agents_m365_to_0,NA,binary,count,678,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,beta_blocking_agents_m365_to_0,NA,binary,%,19.2558932121556,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,calicum_channel_blockers_m365_to_0,NA,binary,count,556,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,calicum_channel_blockers_m365_to_0,NA,binary,%,15.7909684748651,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,chronic_kidney_disease_minf_to_0,NA,binary,count,283,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,chronic_kidney_disease_minf_to_0,NA,binary,%,8.03748934961659,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,chronic_liver_disease_minf_to_0,NA,binary,count,283,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,chronic_liver_disease_minf_to_0,NA,binary,%,8.03748934961659,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,copd_minf_to_0,NA,binary,count,289,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,copd_minf_to_0,NA,binary,%,8.20789548423743,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,covid_minf_to_0,NA,binary,count,310,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,covid_minf_to_0,NA,binary,%,8.80431695541039,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,dementia_minf_to_0,NA,binary,count,45,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,dementia_minf_to_0,NA,binary,%,1.27804600965635,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,depressive_disorder_minf_to_0,NA,binary,count,790,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,depressive_disorder_minf_to_0,NA,binary,%,22.4368077250781,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,diabetes_minf_to_0,NA,binary,count,643,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,diabetes_minf_to_0,NA,binary,%,18.2618574268674,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,diuretics_m365_to_0,NA,binary,count,655,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,diuretics_m365_to_0,NA,binary,%,18.6026696961091,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,drugs_acid_related_disorder_m365_to_0,NA,binary,count,1005,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,drugs_acid_related_disorder_m365_to_0,NA,binary,%,28.5430275489918,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,863,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,24.5100823629651,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,drugs_used_in_diabetes_m365_to_0,NA,binary,count,482,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,drugs_used_in_diabetes_m365_to_0,NA,binary,%,13.6892928145413,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,gerd_minf_to_0,NA,binary,count,989,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,gerd_minf_to_0,NA,binary,%,28.0886111900028,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,heart_failure_minf_to_0,NA,binary,count,170,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,heart_failure_minf_to_0,NA,binary,%,4.82817381425731,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,hiv_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,hiv_minf_to_0,NA,binary,%,0.0568020448736154,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,263,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,7.46946890088043,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,hypertension_minf_to_0,NA,binary,count,1753,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,hypertension_minf_to_0,NA,binary,%,49.7869923317239,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,hypothyroidism_minf_to_0,NA,binary,count,628,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,hypothyroidism_minf_to_0,NA,binary,%,17.8358420903152,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,immunosupressants_m365_to_0,NA,binary,count,3521,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,immunosupressants_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,infertility_minf_to_0,NA,binary,count,30,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,infertility_minf_to_0,NA,binary,%,0.852030673104232,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,inflammatory_bowel_disease_minf_to_0,NA,binary,count,148,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,inflammatory_bowel_disease_minf_to_0,NA,binary,%,4.20335132064754,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,lipid_modifying_agents_m365_to_0,NA,binary,count,1006,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,lipid_modifying_agents_m365_to_0,NA,binary,%,28.5714285714286,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,malaria_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,malaria_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,malignant_neoplastic_disease_minf_to_0,NA,binary,count,547,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,malignant_neoplastic_disease_minf_to_0,NA,binary,%,15.5353592729338,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,myocardial_infarction_minf_to_0,NA,binary,count,52,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,myocardial_infarction_minf_to_0,NA,binary,%,1.476853166714,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,opioids_m365_to_0,NA,binary,count,1086,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,opioids_m365_to_0,NA,binary,%,30.8435103663732,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,osteoporosis_minf_to_0,NA,binary,count,371,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,osteoporosis_minf_to_0,NA,binary,%,10.5367793240557,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,pneumonia_minf_to_0,NA,binary,count,241,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,pneumonia_minf_to_0,NA,binary,%,6.84464640727066,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,psycholeptics_m365_to_0,NA,binary,count,960,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,psycholeptics_m365_to_0,NA,binary,%,27.2649815393354,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,psychostimulants_m365_to_0,NA,binary,count,82,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,psychostimulants_m365_to_0,NA,binary,%,2.32888383981823,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,rheumatoid_arthritis_minf_to_0,NA,binary,count,1843,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,rheumatoid_arthritis_minf_to_0,NA,binary,%,52.3430843510366,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,stroke_minf_to_0,NA,binary,count,68,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,stroke_minf_to_0,NA,binary,%,1.93126952570293,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,venous_thromboembolism_minf_to_0,NA,binary,count,98,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,venous_thromboembolism_minf_to_0,NA,binary,%,2.78330019880716,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age_group,0 to 19,categorical,count,105,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age_group,0 to 19,categorical,%,2.98210735586481,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age_group,20 to 39,categorical,count,408,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age_group,20 to 39,categorical,%,11.5876171542176,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age_group,40 to 59,categorical,count,1387,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age_group,40 to 59,categorical,%,39.3922181198523,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age_group,60 to 79,categorical,count,1378,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age_group,60 to 79,categorical,%,39.136608917921,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age_group,80 to 150,categorical,count,243,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,age_group,80 to 150,categorical,%,6.90144845214428,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,indication,covid,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,indication,covid,categorical,%,0.0568020448736154,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,indication,multiple,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,indication,multiple,categorical,%,0.0568020448736154,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,indication,none,categorical,count,1675,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,indication,none,categorical,%,47.5717125816529,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,indication,rheumatoid_arthritis,categorical,count,1842,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,indication,rheumatoid_arthritis,categorical,%,52.3146833285998,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,indication,malaria,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,indication,malaria,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,sex,Female,categorical,count,2409,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,sex,Female,categorical,%,68.4180630502698,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,sex,Male,categorical,count,1112,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,sex,Male,categorical,%,31.5819369497302,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,window,during_hcq_use_for_covid,categorical,count,3521,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,window,during_hcq_use_for_covid,categorical,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,window,before_pandemic,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,window,before_pandemic,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,window,after_fda_retraction,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Calendar time,during_hcq_use_for_covid,window,after_fda_retraction,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,number subjects,NA,NA,count,99,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,number records,NA,NA,count,99,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,age,NA,numeric,median,55,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,age,NA,numeric,q25,41,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,age,NA,numeric,q75,64.5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,future_observation,NA,numeric,median,170,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,future_observation,NA,numeric,q25,81.5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,future_observation,NA,numeric,q75,398,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,prior_history,NA,numeric,median,821,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,prior_history,NA,numeric,q25,480,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,prior_history,NA,numeric,q75,1502.5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,cohort_end_date,NA,date,median,2021-12-25,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,cohort_end_date,NA,date,q25,2021-06-20,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,cohort_end_date,NA,date,q75,2022-04-04,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,cohort_start_date,NA,date,median,2021-09-02,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,cohort_start_date,NA,date,q25,2021-02-14,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,cohort_start_date,NA,date,q75,2021-12-28,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,29,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,29.2929292929293,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,antibacterials_systemic_m365_to_0,NA,binary,count,72,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,antibacterials_systemic_m365_to_0,NA,binary,%,72.7272727272727,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,antidepressants_m365_to_0,NA,binary,count,40,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,antidepressants_m365_to_0,NA,binary,%,40.4040404040404,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,antiepileptics_m365_to_0,NA,binary,count,26,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,antiepileptics_m365_to_0,NA,binary,%,26.2626262626263,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,80,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,80.8080808080808,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,antineoplastic_agents_m365_to_0,NA,binary,count,99,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,antineoplastic_agents_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,antithrombotics_m365_to_0,NA,binary,count,28,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,antithrombotics_m365_to_0,NA,binary,%,28.2828282828283,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,anxiety_minf_to_0,NA,binary,count,36,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,anxiety_minf_to_0,NA,binary,%,36.3636363636364,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,asthma_minf_to_0,NA,binary,count,17,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,asthma_minf_to_0,NA,binary,%,17.1717171717172,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,beta_blocking_agents_m365_to_0,NA,binary,count,21,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,beta_blocking_agents_m365_to_0,NA,binary,%,21.2121212121212,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,calicum_channel_blockers_m365_to_0,NA,binary,count,18,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,calicum_channel_blockers_m365_to_0,NA,binary,%,18.1818181818182,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,chronic_kidney_disease_minf_to_0,NA,binary,count,10,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,chronic_kidney_disease_minf_to_0,NA,binary,%,10.1010101010101,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,chronic_liver_disease_minf_to_0,NA,binary,count,10,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,chronic_liver_disease_minf_to_0,NA,binary,%,10.1010101010101,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,copd_minf_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,copd_minf_to_0,NA,binary,%,7.07070707070707,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,covid_minf_to_0,NA,binary,count,99,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,covid_minf_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,dementia_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,dementia_minf_to_0,NA,binary,%,1.01010101010101,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,depressive_disorder_minf_to_0,NA,binary,count,27,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,depressive_disorder_minf_to_0,NA,binary,%,27.2727272727273,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,diabetes_minf_to_0,NA,binary,count,27,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,diabetes_minf_to_0,NA,binary,%,27.2727272727273,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,diuretics_m365_to_0,NA,binary,count,27,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,diuretics_m365_to_0,NA,binary,%,27.2727272727273,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,drugs_acid_related_disorder_m365_to_0,NA,binary,count,38,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,drugs_acid_related_disorder_m365_to_0,NA,binary,%,38.3838383838384,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,51,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,51.5151515151515,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,drugs_used_in_diabetes_m365_to_0,NA,binary,count,18,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,drugs_used_in_diabetes_m365_to_0,NA,binary,%,18.1818181818182,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,gerd_minf_to_0,NA,binary,count,37,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,gerd_minf_to_0,NA,binary,%,37.3737373737374,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,heart_failure_minf_to_0,NA,binary,count,8,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,heart_failure_minf_to_0,NA,binary,%,8.08080808080808,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,hiv_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,hiv_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,6,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,6.06060606060606,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,hypertension_minf_to_0,NA,binary,count,50,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,hypertension_minf_to_0,NA,binary,%,50.5050505050505,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,hypothyroidism_minf_to_0,NA,binary,count,14,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,hypothyroidism_minf_to_0,NA,binary,%,14.1414141414141,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,immunosupressants_m365_to_0,NA,binary,count,99,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,immunosupressants_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,infertility_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,infertility_minf_to_0,NA,binary,%,1.01010101010101,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,inflammatory_bowel_disease_minf_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,inflammatory_bowel_disease_minf_to_0,NA,binary,%,7.07070707070707,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,lipid_modifying_agents_m365_to_0,NA,binary,count,30,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,lipid_modifying_agents_m365_to_0,NA,binary,%,30.3030303030303,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,malaria_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,malaria_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,malignant_neoplastic_disease_minf_to_0,NA,binary,count,20,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,malignant_neoplastic_disease_minf_to_0,NA,binary,%,20.2020202020202,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,myocardial_infarction_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,myocardial_infarction_minf_to_0,NA,binary,%,3.03030303030303,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,opioids_m365_to_0,NA,binary,count,35,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,opioids_m365_to_0,NA,binary,%,35.3535353535354,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,osteoporosis_minf_to_0,NA,binary,count,9,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,osteoporosis_minf_to_0,NA,binary,%,9.09090909090909,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,pneumonia_minf_to_0,NA,binary,count,25,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,pneumonia_minf_to_0,NA,binary,%,25.2525252525253,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,psycholeptics_m365_to_0,NA,binary,count,38,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,psycholeptics_m365_to_0,NA,binary,%,38.3838383838384,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,psychostimulants_m365_to_0,NA,binary,count,5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,psychostimulants_m365_to_0,NA,binary,%,5.05050505050505,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,rheumatoid_arthritis_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,rheumatoid_arthritis_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,stroke_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,stroke_minf_to_0,NA,binary,%,2.02020202020202,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,venous_thromboembolism_minf_to_0,NA,binary,count,8,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,venous_thromboembolism_minf_to_0,NA,binary,%,8.08080808080808,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,age_group,0 to 19,categorical,count,6,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,age_group,0 to 19,categorical,%,6.06060606060606,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,age_group,20 to 39,categorical,count,18,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,age_group,20 to 39,categorical,%,18.1818181818182,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,age_group,40 to 59,categorical,count,35,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,age_group,40 to 59,categorical,%,35.3535353535354,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,age_group,60 to 79,categorical,count,34,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,age_group,60 to 79,categorical,%,34.3434343434343,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,age_group,80 to 150,categorical,count,6,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,age_group,80 to 150,categorical,%,6.06060606060606,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,indication,covid,categorical,count,99,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,indication,covid,categorical,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,indication,rheumatoid_arthritis,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,indication,rheumatoid_arthritis,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,indication,none,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,indication,none,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,indication,multiple,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,indication,multiple,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,indication,malaria,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,indication,malaria,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,sex,Female,categorical,count,60,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,sex,Female,categorical,%,60.6060606060606,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,sex,Male,categorical,count,39,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,sex,Male,categorical,%,39.3939393939394,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,window,after_fda_retraction,categorical,count,96,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,window,after_fda_retraction,categorical,%,96.969696969697,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,window,before_pandemic,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,window,before_pandemic,categorical,%,1.01010101010101,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,window,during_hcq_use_for_covid,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,covid,window,during_hcq_use_for_covid,categorical,%,2.02020202020202,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,number subjects,NA,NA,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,number records,NA,NA,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,age,NA,numeric,median,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,age,NA,numeric,q25,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,age,NA,numeric,q75,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,future_observation,NA,numeric,median,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,future_observation,NA,numeric,q25,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,future_observation,NA,numeric,q75,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,prior_history,NA,numeric,median,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,prior_history,NA,numeric,q25,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,prior_history,NA,numeric,q75,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,cohort_end_date,NA,date,median,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,cohort_end_date,NA,date,q25,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,cohort_end_date,NA,date,q75,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,cohort_start_date,NA,date,median,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,cohort_start_date,NA,date,q25,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,cohort_start_date,NA,date,q75,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,antibacterials_systemic_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,antibacterials_systemic_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,antidepressants_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,antidepressants_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,antiepileptics_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,antiepileptics_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,antineoplastic_agents_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,antineoplastic_agents_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,antithrombotics_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,antithrombotics_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,anxiety_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,anxiety_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,asthma_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,asthma_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,beta_blocking_agents_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,beta_blocking_agents_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,calicum_channel_blockers_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,calicum_channel_blockers_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,chronic_kidney_disease_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,chronic_kidney_disease_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,chronic_liver_disease_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,chronic_liver_disease_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,copd_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,copd_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,covid_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,covid_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,dementia_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,dementia_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,depressive_disorder_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,depressive_disorder_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,diabetes_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,diabetes_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,diuretics_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,diuretics_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,drugs_acid_related_disorder_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,drugs_acid_related_disorder_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,drugs_used_in_diabetes_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,drugs_used_in_diabetes_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,gerd_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,gerd_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,heart_failure_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,heart_failure_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,hiv_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,hiv_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,hypertension_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,hypertension_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,hypothyroidism_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,hypothyroidism_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,immunosupressants_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,immunosupressants_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,infertility_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,infertility_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,inflammatory_bowel_disease_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,inflammatory_bowel_disease_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,lipid_modifying_agents_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,lipid_modifying_agents_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,malaria_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,malaria_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,malignant_neoplastic_disease_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,malignant_neoplastic_disease_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,myocardial_infarction_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,myocardial_infarction_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,number_visits,NA,numeric,median,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,number_visits,NA,numeric,q25,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,number_visits,NA,numeric,q75,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,opioids_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,opioids_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,osteoporosis_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,osteoporosis_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,pneumonia_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,pneumonia_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,psycholeptics_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,psycholeptics_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,psychostimulants_m365_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,psychostimulants_m365_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,rheumatoid_arthritis_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,rheumatoid_arthritis_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,stroke_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,stroke_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,venous_thromboembolism_minf_to_0,NA,binary,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,venous_thromboembolism_minf_to_0,NA,binary,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,age_group,40 to 59,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,age_group,40 to 59,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,age_group,60 to 79,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,age_group,60 to 79,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,age_group,0 to 19,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,age_group,0 to 19,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,age_group,20 to 39,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,age_group,20 to 39,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,age_group,80 to 150,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,age_group,80 to 150,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,indication,malaria,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,indication,malaria,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,indication,rheumatoid_arthritis,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,indication,rheumatoid_arthritis,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,indication,none,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,indication,none,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,indication,covid,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,indication,covid,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,indication,multiple,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,indication,multiple,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,sex,Female,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,sex,Female,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,sex,Male,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,sex,Male,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,window,after_fda_retraction,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,window,after_fda_retraction,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,window,before_pandemic,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,window,before_pandemic,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,window,during_hcq_use_for_covid,categorical,count,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,malaria,window,during_hcq_use_for_covid,categorical,%,NA,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,number subjects,NA,NA,count,101,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,number records,NA,NA,count,101,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age,NA,numeric,median,61,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age,NA,numeric,q25,52,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age,NA,numeric,q75,72,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,future_observation,NA,numeric,median,158.5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,future_observation,NA,numeric,q25,55,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,future_observation,NA,numeric,q75,368,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,prior_history,NA,numeric,median,765.5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,prior_history,NA,numeric,q25,446,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,prior_history,NA,numeric,q75,1432,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,cohort_end_date,NA,date,median,2022-03-04,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,cohort_end_date,NA,date,q25,2021-06-09,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,cohort_end_date,NA,date,q75,2022-04-20,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,cohort_start_date,NA,date,median,2021-09-18,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,cohort_start_date,NA,date,q25,2021-02-06,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,cohort_start_date,NA,date,q75,2022-02-04,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,38,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,37.6237623762376,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,antibacterials_systemic_m365_to_0,NA,binary,count,75,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,antibacterials_systemic_m365_to_0,NA,binary,%,74.2574257425743,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,antidepressants_m365_to_0,NA,binary,count,44,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,antidepressants_m365_to_0,NA,binary,%,43.5643564356436,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,antiepileptics_m365_to_0,NA,binary,count,38,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,antiepileptics_m365_to_0,NA,binary,%,37.6237623762376,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,96,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,95.049504950495,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,antineoplastic_agents_m365_to_0,NA,binary,count,101,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,antineoplastic_agents_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,antithrombotics_m365_to_0,NA,binary,count,18,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,antithrombotics_m365_to_0,NA,binary,%,17.8217821782178,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,anxiety_minf_to_0,NA,binary,count,28,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,anxiety_minf_to_0,NA,binary,%,27.7227722772277,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,asthma_minf_to_0,NA,binary,count,20,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,asthma_minf_to_0,NA,binary,%,19.8019801980198,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,beta_blocking_agents_m365_to_0,NA,binary,count,28,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,beta_blocking_agents_m365_to_0,NA,binary,%,27.7227722772277,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,calicum_channel_blockers_m365_to_0,NA,binary,count,28,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,calicum_channel_blockers_m365_to_0,NA,binary,%,27.7227722772277,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,chronic_kidney_disease_minf_to_0,NA,binary,count,17,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,chronic_kidney_disease_minf_to_0,NA,binary,%,16.8316831683168,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,chronic_liver_disease_minf_to_0,NA,binary,count,17,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,chronic_liver_disease_minf_to_0,NA,binary,%,16.8316831683168,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,copd_minf_to_0,NA,binary,count,23,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,copd_minf_to_0,NA,binary,%,22.7722772277228,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,covid_minf_to_0,NA,binary,count,98,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,covid_minf_to_0,NA,binary,%,97.029702970297,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,dementia_minf_to_0,NA,binary,count,6,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,dementia_minf_to_0,NA,binary,%,5.94059405940594,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,depressive_disorder_minf_to_0,NA,binary,count,25,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,depressive_disorder_minf_to_0,NA,binary,%,24.7524752475248,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,diabetes_minf_to_0,NA,binary,count,37,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,diabetes_minf_to_0,NA,binary,%,36.6336633663366,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,diuretics_m365_to_0,NA,binary,count,31,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,diuretics_m365_to_0,NA,binary,%,30.6930693069307,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,drugs_acid_related_disorder_m365_to_0,NA,binary,count,48,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,drugs_acid_related_disorder_m365_to_0,NA,binary,%,47.5247524752475,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,48,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,47.5247524752475,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,drugs_used_in_diabetes_m365_to_0,NA,binary,count,30,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,drugs_used_in_diabetes_m365_to_0,NA,binary,%,29.7029702970297,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,gerd_minf_to_0,NA,binary,count,45,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,gerd_minf_to_0,NA,binary,%,44.5544554455446,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,heart_failure_minf_to_0,NA,binary,count,19,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,heart_failure_minf_to_0,NA,binary,%,18.8118811881188,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,hiv_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,hiv_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,1.98019801980198,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,hypertension_minf_to_0,NA,binary,count,65,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,hypertension_minf_to_0,NA,binary,%,64.3564356435644,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,hypothyroidism_minf_to_0,NA,binary,count,23,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,hypothyroidism_minf_to_0,NA,binary,%,22.7722772277228,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,immunosupressants_m365_to_0,NA,binary,count,101,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,immunosupressants_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,infertility_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,infertility_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,inflammatory_bowel_disease_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,inflammatory_bowel_disease_minf_to_0,NA,binary,%,2.97029702970297,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,lipid_modifying_agents_m365_to_0,NA,binary,count,45,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,lipid_modifying_agents_m365_to_0,NA,binary,%,44.5544554455446,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,malaria_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,malaria_minf_to_0,NA,binary,%,2.97029702970297,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,malignant_neoplastic_disease_minf_to_0,NA,binary,count,12,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,malignant_neoplastic_disease_minf_to_0,NA,binary,%,11.8811881188119,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,myocardial_infarction_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,myocardial_infarction_minf_to_0,NA,binary,%,2.97029702970297,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,opioids_m365_to_0,NA,binary,count,37,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,opioids_m365_to_0,NA,binary,%,36.6336633663366,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,osteoporosis_minf_to_0,NA,binary,count,20,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,osteoporosis_minf_to_0,NA,binary,%,19.8019801980198,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,pneumonia_minf_to_0,NA,binary,count,36,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,pneumonia_minf_to_0,NA,binary,%,35.6435643564356,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,psycholeptics_m365_to_0,NA,binary,count,32,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,psycholeptics_m365_to_0,NA,binary,%,31.6831683168317,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,psychostimulants_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,psychostimulants_m365_to_0,NA,binary,%,0.99009900990099,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,rheumatoid_arthritis_minf_to_0,NA,binary,count,101,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,rheumatoid_arthritis_minf_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,stroke_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,stroke_minf_to_0,NA,binary,%,3.96039603960396,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,venous_thromboembolism_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,venous_thromboembolism_minf_to_0,NA,binary,%,1.98019801980198,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age_group,20 to 39,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age_group,20 to 39,categorical,%,0.99009900990099,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age_group,40 to 59,categorical,count,40,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age_group,40 to 59,categorical,%,39.6039603960396,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age_group,60 to 79,categorical,count,53,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age_group,60 to 79,categorical,%,52.4752475247525,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age_group,80 to 150,categorical,count,7,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age_group,80 to 150,categorical,%,6.93069306930693,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age_group,0 to 19,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,age_group,0 to 19,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,indication,multiple,categorical,count,101,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,indication,multiple,categorical,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,indication,rheumatoid_arthritis,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,indication,rheumatoid_arthritis,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,indication,none,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,indication,none,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,indication,covid,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,indication,covid,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,indication,malaria,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,indication,malaria,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,sex,Female,categorical,count,83,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,sex,Female,categorical,%,82.1782178217822,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,sex,Male,categorical,count,18,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,sex,Male,categorical,%,17.8217821782178,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,window,after_fda_retraction,categorical,count,96,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,window,after_fda_retraction,categorical,%,95.049504950495,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,window,before_pandemic,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,window,before_pandemic,categorical,%,2.97029702970297,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,window,during_hcq_use_for_covid,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,multiple,window,during_hcq_use_for_covid,categorical,%,1.98019801980198,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,number subjects,NA,NA,count,18218,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,number records,NA,NA,count,18218,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age,NA,numeric,median,55,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age,NA,numeric,q25,41,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age,NA,numeric,q75,65,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,future_observation,NA,numeric,median,400,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,future_observation,NA,numeric,q25,175,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,future_observation,NA,numeric,q75,763,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,prior_history,NA,numeric,median,807,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,prior_history,NA,numeric,q25,653,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,prior_history,NA,numeric,q75,1143,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,cohort_end_date,NA,date,median,2020-08-24,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,cohort_end_date,NA,date,q25,2019-09-28,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,cohort_end_date,NA,date,q75,2021-09-15,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,cohort_start_date,NA,date,median,2020-02-25,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,cohort_start_date,NA,date,q25,2019-04-18,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,cohort_start_date,NA,date,q75,2021-03-17,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,4767,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,26.1664288066747,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,antibacterials_systemic_m365_to_0,NA,binary,count,9725,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,antibacterials_systemic_m365_to_0,NA,binary,%,53.3812712701724,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,antidepressants_m365_to_0,NA,binary,count,5497,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,antidepressants_m365_to_0,NA,binary,%,30.1734548248985,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,antiepileptics_m365_to_0,NA,binary,count,3553,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,antiepileptics_m365_to_0,NA,binary,%,19.5026896476013,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,12581,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,69.0580744318806,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,antineoplastic_agents_m365_to_0,NA,binary,count,18218,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,antineoplastic_agents_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,antithrombotics_m365_to_0,NA,binary,count,2197,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,antithrombotics_m365_to_0,NA,binary,%,12.0595015918323,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,anxiety_minf_to_0,NA,binary,count,4985,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,anxiety_minf_to_0,NA,binary,%,27.3630475354045,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,asthma_minf_to_0,NA,binary,count,2453,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,asthma_minf_to_0,NA,binary,%,13.4647052365792,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,beta_blocking_agents_m365_to_0,NA,binary,count,3401,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,beta_blocking_agents_m365_to_0,NA,binary,%,18.6683499835328,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,calicum_channel_blockers_m365_to_0,NA,binary,count,2530,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,calicum_channel_blockers_m365_to_0,NA,binary,%,13.8873641453508,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,chronic_kidney_disease_minf_to_0,NA,binary,count,1408,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,chronic_kidney_disease_minf_to_0,NA,binary,%,7.72862004610824,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,chronic_liver_disease_minf_to_0,NA,binary,count,1408,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,chronic_liver_disease_minf_to_0,NA,binary,%,7.72862004610824,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,copd_minf_to_0,NA,binary,count,1240,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,copd_minf_to_0,NA,binary,%,6.80645515424306,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,covid_minf_to_0,NA,binary,count,2733,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,covid_minf_to_0,NA,binary,%,15.0016467230212,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,dementia_minf_to_0,NA,binary,count,163,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,dementia_minf_to_0,NA,binary,%,0.894719508178724,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,depressive_disorder_minf_to_0,NA,binary,count,3994,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,depressive_disorder_minf_to_0,NA,binary,%,21.9233724887474,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,diabetes_minf_to_0,NA,binary,count,3073,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,diabetes_minf_to_0,NA,binary,%,16.8679328137007,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,diuretics_m365_to_0,NA,binary,count,3092,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,diuretics_m365_to_0,NA,binary,%,16.9722252717093,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,drugs_acid_related_disorder_m365_to_0,NA,binary,count,5009,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,drugs_acid_related_disorder_m365_to_0,NA,binary,%,27.4947853770996,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,4236,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,23.2517290591722,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,drugs_used_in_diabetes_m365_to_0,NA,binary,count,2548,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,drugs_used_in_diabetes_m365_to_0,NA,binary,%,13.986167526622,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,gerd_minf_to_0,NA,binary,count,4524,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,gerd_minf_to_0,NA,binary,%,24.8325831595126,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,heart_failure_minf_to_0,NA,binary,count,846,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,heart_failure_minf_to_0,NA,binary,%,4.6437589197497,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,hiv_minf_to_0,NA,binary,count,32,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,hiv_minf_to_0,NA,binary,%,0.175650455593369,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,1309,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,7.18520144911626,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,hypertension_minf_to_0,NA,binary,count,8176,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,hypertension_minf_to_0,NA,binary,%,44.8786914041058,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,hypothyroidism_minf_to_0,NA,binary,count,2948,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,hypothyroidism_minf_to_0,NA,binary,%,16.1817982215391,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,immunosupressants_m365_to_0,NA,binary,count,18218,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,immunosupressants_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,infertility_minf_to_0,NA,binary,count,193,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,infertility_minf_to_0,NA,binary,%,1.05939181029751,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,inflammatory_bowel_disease_minf_to_0,NA,binary,count,1312,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,inflammatory_bowel_disease_minf_to_0,NA,binary,%,7.20166867932814,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,lipid_modifying_agents_m365_to_0,NA,binary,count,4940,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,lipid_modifying_agents_m365_to_0,NA,binary,%,27.1160390822264,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,malaria_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,malaria_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,malignant_neoplastic_disease_minf_to_0,NA,binary,count,3094,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,malignant_neoplastic_disease_minf_to_0,NA,binary,%,16.9832034251839,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,myocardial_infarction_minf_to_0,NA,binary,count,247,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,myocardial_infarction_minf_to_0,NA,binary,%,1.35580195411132,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,opioids_m365_to_0,NA,binary,count,5229,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,opioids_m365_to_0,NA,binary,%,28.702382259304,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,osteoporosis_minf_to_0,NA,binary,count,1189,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,osteoporosis_minf_to_0,NA,binary,%,6.52651224064112,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,pneumonia_minf_to_0,NA,binary,count,1139,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,pneumonia_minf_to_0,NA,binary,%,6.25205840377649,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,psycholeptics_m365_to_0,NA,binary,count,5279,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,psycholeptics_m365_to_0,NA,binary,%,28.9768360961686,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,psychostimulants_m365_to_0,NA,binary,count,631,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,psychostimulants_m365_to_0,NA,binary,%,3.46360742123175,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,rheumatoid_arthritis_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,rheumatoid_arthritis_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,stroke_minf_to_0,NA,binary,count,325,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,stroke_minf_to_0,NA,binary,%,1.78394993962016,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,venous_thromboembolism_minf_to_0,NA,binary,count,515,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,venous_thromboembolism_minf_to_0,NA,binary,%,2.82687451970579,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age_group,0 to 19,categorical,count,1066,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age_group,0 to 19,categorical,%,5.85135580195411,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age_group,20 to 39,categorical,count,3175,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age_group,20 to 39,categorical,%,17.4278186409046,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age_group,40 to 59,categorical,count,6941,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age_group,40 to 59,categorical,%,38.0996816335492,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age_group,60 to 79,categorical,count,6035,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age_group,60 to 79,categorical,%,33.126578109562,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age_group,80 to 150,categorical,count,1001,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,age_group,80 to 150,categorical,%,5.49456581403008,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,indication,none,categorical,count,18218,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,indication,none,categorical,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,indication,rheumatoid_arthritis,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,indication,rheumatoid_arthritis,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,indication,covid,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,indication,covid,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,indication,multiple,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,indication,multiple,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,indication,malaria,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,indication,malaria,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,sex,Female,categorical,count,11515,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,sex,Female,categorical,%,63.2067186299264,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,sex,Male,categorical,count,6703,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,sex,Male,categorical,%,36.7932813700736,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,window,after_fda_retraction,categorical,count,7803,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,window,after_fda_retraction,categorical,%,42.8312657810956,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,window,before_pandemic,categorical,count,8740,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,window,before_pandemic,categorical,%,47.974530683939,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,window,during_hcq_use_for_covid,categorical,count,1675,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,none,window,during_hcq_use_for_covid,categorical,%,9.19420353496542,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,number subjects,NA,NA,count,19078,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,number records,NA,NA,count,19078,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age,NA,numeric,median,62,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age,NA,numeric,q25,53,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age,NA,numeric,q75,71,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,future_observation,NA,numeric,median,452,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,future_observation,NA,numeric,q25,197,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,future_observation,NA,numeric,q75,835,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,prior_history,NA,numeric,median,737,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,prior_history,NA,numeric,q25,624,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,prior_history,NA,numeric,q75,1070,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,cohort_end_date,NA,date,median,2020-08-23,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,cohort_end_date,NA,date,q25,2019-09-19,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,cohort_end_date,NA,date,q75,2021-10-14,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,cohort_start_date,NA,date,median,2020-01-09,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,cohort_start_date,NA,date,q25,2019-02-01,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,cohort_start_date,NA,date,q75,2021-01-27,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,6238,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,32.6973477303701,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,antibacterials_systemic_m365_to_0,NA,binary,count,10238,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,antibacterials_systemic_m365_to_0,NA,binary,%,53.6639060698186,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,antidepressants_m365_to_0,NA,binary,count,6140,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,antidepressants_m365_to_0,NA,binary,%,32.1836670510536,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,antiepileptics_m365_to_0,NA,binary,count,4318,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,antiepileptics_m365_to_0,NA,binary,%,22.6333997274347,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,14833,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,77.7492399622602,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,antineoplastic_agents_m365_to_0,NA,binary,count,19078,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,antineoplastic_agents_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,antithrombotics_m365_to_0,NA,binary,count,2459,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,antithrombotics_m365_to_0,NA,binary,%,12.889191739176,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,anxiety_minf_to_0,NA,binary,count,4803,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,anxiety_minf_to_0,NA,binary,%,25.1755949260929,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,asthma_minf_to_0,NA,binary,count,2676,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,asthma_minf_to_0,NA,binary,%,14.0266275290911,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,beta_blocking_agents_m365_to_0,NA,binary,count,4241,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,beta_blocking_agents_m365_to_0,NA,binary,%,22.2297934794004,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,calicum_channel_blockers_m365_to_0,NA,binary,count,3201,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,calicum_channel_blockers_m365_to_0,NA,binary,%,16.7784883111437,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,chronic_kidney_disease_minf_to_0,NA,binary,count,1793,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,chronic_kidney_disease_minf_to_0,NA,binary,%,9.39825977565783,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,chronic_liver_disease_minf_to_0,NA,binary,count,1793,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,chronic_liver_disease_minf_to_0,NA,binary,%,9.39825977565783,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,copd_minf_to_0,NA,binary,count,2074,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,copd_minf_to_0,NA,binary,%,10.8711604990041,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,covid_minf_to_0,NA,binary,count,2335,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,covid_minf_to_0,NA,binary,%,12.2392284306531,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,dementia_minf_to_0,NA,binary,count,333,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,dementia_minf_to_0,NA,binary,%,1.74546598175909,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,depressive_disorder_minf_to_0,NA,binary,count,4268,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,depressive_disorder_minf_to_0,NA,binary,%,22.3713177481916,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,diabetes_minf_to_0,NA,binary,count,3589,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,diabetes_minf_to_0,NA,binary,%,18.8122444700702,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,diuretics_m365_to_0,NA,binary,count,3965,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,diuretics_m365_to_0,NA,binary,%,20.7831009539784,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,drugs_acid_related_disorder_m365_to_0,NA,binary,count,5635,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,drugs_acid_related_disorder_m365_to_0,NA,binary,%,29.5366390606982,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,5064,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,26.5436628577419,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,drugs_used_in_diabetes_m365_to_0,NA,binary,count,2705,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,drugs_used_in_diabetes_m365_to_0,NA,binary,%,14.1786350770521,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,gerd_minf_to_0,NA,binary,count,5440,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,gerd_minf_to_0,NA,binary,%,28.5145193416501,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,heart_failure_minf_to_0,NA,binary,count,1191,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,heart_failure_minf_to_0,NA,binary,%,6.24279274557081,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,hiv_minf_to_0,NA,binary,count,18,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,hiv_minf_to_0,NA,binary,%,0.0943495125275186,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,998,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,5.23115630569242,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,hypertension_minf_to_0,NA,binary,count,10414,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,hypertension_minf_to_0,NA,binary,%,54.5864346367544,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,hypothyroidism_minf_to_0,NA,binary,count,3988,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,hypothyroidism_minf_to_0,NA,binary,%,20.9036586644302,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,immunosupressants_m365_to_0,NA,binary,count,19078,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,immunosupressants_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,infertility_minf_to_0,NA,binary,count,22,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,infertility_minf_to_0,NA,binary,%,0.115316070866967,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,inflammatory_bowel_disease_minf_to_0,NA,binary,count,338,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,inflammatory_bowel_disease_minf_to_0,NA,binary,%,1.77167417968341,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,lipid_modifying_agents_m365_to_0,NA,binary,count,6480,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,lipid_modifying_agents_m365_to_0,NA,binary,%,33.9658245099067,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,malaria_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,malaria_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,malignant_neoplastic_disease_minf_to_0,NA,binary,count,2652,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,malignant_neoplastic_disease_minf_to_0,NA,binary,%,13.9008281790544,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,myocardial_infarction_minf_to_0,NA,binary,count,377,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,myocardial_infarction_minf_to_0,NA,binary,%,1.97609812349303,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,opioids_m365_to_0,NA,binary,count,6019,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,opioids_m365_to_0,NA,binary,%,31.5494286612853,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,osteoporosis_minf_to_0,NA,binary,count,3157,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,osteoporosis_minf_to_0,NA,binary,%,16.5478561694098,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,pneumonia_minf_to_0,NA,binary,count,1500,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,pneumonia_minf_to_0,NA,binary,%,7.86245937729322,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,psycholeptics_m365_to_0,NA,binary,count,4929,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,psycholeptics_m365_to_0,NA,binary,%,25.8360415137855,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,psychostimulants_m365_to_0,NA,binary,count,421,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,psychostimulants_m365_to_0,NA,binary,%,2.20673026522696,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,rheumatoid_arthritis_minf_to_0,NA,binary,count,19065,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,rheumatoid_arthritis_minf_to_0,NA,binary,%,99.9318586853968,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,stroke_minf_to_0,NA,binary,count,500,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,stroke_minf_to_0,NA,binary,%,2.62081979243107,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,venous_thromboembolism_minf_to_0,NA,binary,count,603,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,venous_thromboembolism_minf_to_0,NA,binary,%,3.16070866967187,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age_group,0 to 19,categorical,count,207,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age_group,0 to 19,categorical,%,1.08501939406646,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age_group,20 to 39,categorical,count,1229,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age_group,20 to 39,categorical,%,6.44197504979558,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age_group,40 to 59,categorical,count,6779,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age_group,40 to 59,categorical,%,35.5330747457805,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age_group,60 to 79,categorical,count,8959,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age_group,60 to 79,categorical,%,46.95984904078,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age_group,80 to 150,categorical,count,1904,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,age_group,80 to 150,categorical,%,9.98008176957752,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,indication,rheumatoid_arthritis,categorical,count,19078,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,indication,rheumatoid_arthritis,categorical,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,indication,none,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,indication,none,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,indication,covid,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,indication,covid,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,indication,multiple,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,indication,multiple,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,indication,malaria,categorical,count,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,indication,malaria,categorical,%,0,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,sex,Female,categorical,count,14232,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,sex,Female,categorical,%,74.599014571758,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,sex,Male,categorical,count,4846,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,sex,Male,categorical,%,25.400985428242,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,window,after_fda_retraction,categorical,count,7210,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,window,after_fda_retraction,categorical,%,37.7922214068561,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,window,before_pandemic,categorical,count,10026,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,window,before_pandemic,categorical,%,52.5526784778279,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,window,during_hcq_use_for_covid,categorical,count,1842,PHARMETRICS
Cohort name,new_users_methotrexate,Indication,rheumatoid_arthritis,window,during_hcq_use_for_covid,categorical,%,9.65510011531607,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,number subjects,NA,NA,count,37497,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,number records,NA,NA,count,37497,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age,NA,numeric,median,59,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age,NA,numeric,q25,47,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age,NA,numeric,q75,68,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,future_observation,NA,numeric,median,426,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,future_observation,NA,numeric,q25,182,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,future_observation,NA,numeric,q75,798,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,prior_history,NA,numeric,median,771,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,prior_history,NA,numeric,q25,637,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,prior_history,NA,numeric,q75,1108,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,cohort_end_date,NA,date,median,2020-08-26,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,cohort_end_date,NA,date,q25,2019-09-25,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,cohort_end_date,NA,date,q75,2021-10-03,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,cohort_start_date,NA,date,median,2020-01-31,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,cohort_start_date,NA,date,q25,2019-03-13,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,cohort_start_date,NA,date,q75,2021-02-24,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,11073,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,29.5303624289943,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,antibacterials_systemic_m365_to_0,NA,binary,count,20111,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,antibacterials_systemic_m365_to_0,NA,binary,%,53.6336240232552,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,antidepressants_m365_to_0,NA,binary,count,11722,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,antidepressants_m365_to_0,NA,binary,%,31.2611675600715,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,antiepileptics_m365_to_0,NA,binary,count,7935,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,antiepileptics_m365_to_0,NA,binary,%,21.1616929354348,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,27591,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,73.5818865509241,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,antineoplastic_agents_m365_to_0,NA,binary,count,37497,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,antineoplastic_agents_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,antithrombotics_m365_to_0,NA,binary,count,4702,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,antithrombotics_m365_to_0,NA,binary,%,12.5396698402539,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,anxiety_minf_to_0,NA,binary,count,9853,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,anxiety_minf_to_0,NA,binary,%,26.2767688081713,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,asthma_minf_to_0,NA,binary,count,5167,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,asthma_minf_to_0,NA,binary,%,13.7797690481905,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,beta_blocking_agents_m365_to_0,NA,binary,count,7692,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,beta_blocking_agents_m365_to_0,NA,binary,%,20.5136410912873,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,calicum_channel_blockers_m365_to_0,NA,binary,count,5778,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,calicum_channel_blockers_m365_to_0,NA,binary,%,15.4092327386191,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,chronic_kidney_disease_minf_to_0,NA,binary,count,3228,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,chronic_kidney_disease_minf_to_0,NA,binary,%,8.60868869509561,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,chronic_liver_disease_minf_to_0,NA,binary,count,3228,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,chronic_liver_disease_minf_to_0,NA,binary,%,8.60868869509561,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,copd_minf_to_0,NA,binary,count,3344,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,copd_minf_to_0,NA,binary,%,8.9180467770755,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,covid_minf_to_0,NA,binary,count,5265,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,covid_minf_to_0,NA,binary,%,14.0411232898632,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,dementia_minf_to_0,NA,binary,count,503,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,dementia_minf_to_0,NA,binary,%,1.34144064858522,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,depressive_disorder_minf_to_0,NA,binary,count,8314,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,depressive_disorder_minf_to_0,NA,binary,%,22.1724404619036,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,diabetes_minf_to_0,NA,binary,count,6726,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,diabetes_minf_to_0,NA,binary,%,17.9374349947996,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,diuretics_m365_to_0,NA,binary,count,7115,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,diuretics_m365_to_0,NA,binary,%,18.974851321439,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,drugs_acid_related_disorder_m365_to_0,NA,binary,count,10730,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,drugs_acid_related_disorder_m365_to_0,NA,binary,%,28.61562258314,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,9400,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,25.0686721604395,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,drugs_used_in_diabetes_m365_to_0,NA,binary,count,5301,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,drugs_used_in_diabetes_m365_to_0,NA,binary,%,14.1371309704776,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,gerd_minf_to_0,NA,binary,count,10047,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,gerd_minf_to_0,NA,binary,%,26.7941435314825,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,heart_failure_minf_to_0,NA,binary,count,2064,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,heart_failure_minf_to_0,NA,binary,%,5.50444035522842,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,hiv_minf_to_0,NA,binary,count,50,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,hiv_minf_to_0,NA,binary,%,0.133344000853402,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,2315,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,6.17382723951249,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,hypertension_minf_to_0,NA,binary,count,18706,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,hypertension_minf_to_0,NA,binary,%,49.8866575992746,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,hypothyroidism_minf_to_0,NA,binary,count,6973,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,hypothyroidism_minf_to_0,NA,binary,%,18.5961543590154,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,immunosupressants_m365_to_0,NA,binary,count,37497,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,immunosupressants_m365_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,infertility_minf_to_0,NA,binary,count,216,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,infertility_minf_to_0,NA,binary,%,0.576046083686695,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,inflammatory_bowel_disease_minf_to_0,NA,binary,count,1660,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,inflammatory_bowel_disease_minf_to_0,NA,binary,%,4.42702082833293,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,lipid_modifying_agents_m365_to_0,NA,binary,count,11496,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,lipid_modifying_agents_m365_to_0,NA,binary,%,30.6584526762141,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,malaria_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,malaria_minf_to_0,NA,binary,%,0.0106675200682721,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,malignant_neoplastic_disease_minf_to_0,NA,binary,count,5778,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,malignant_neoplastic_disease_minf_to_0,NA,binary,%,15.4092327386191,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,myocardial_infarction_minf_to_0,NA,binary,count,630,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,myocardial_infarction_minf_to_0,NA,binary,%,1.68013441075286,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,opioids_m365_to_0,NA,binary,count,11320,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,opioids_m365_to_0,NA,binary,%,30.1890817932101,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,osteoporosis_minf_to_0,NA,binary,count,4375,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,osteoporosis_minf_to_0,NA,binary,%,11.6676000746726,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,pneumonia_minf_to_0,NA,binary,count,2700,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,pneumonia_minf_to_0,NA,binary,%,7.20057604608369,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,psycholeptics_m365_to_0,NA,binary,count,10279,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,psycholeptics_m365_to_0,NA,binary,%,27.4128596954423,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,psychostimulants_m365_to_0,NA,binary,count,1058,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,psychostimulants_m365_to_0,NA,binary,%,2.82155905805798,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,rheumatoid_arthritis_minf_to_0,NA,binary,count,19166,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,rheumatoid_arthritis_minf_to_0,NA,binary,%,51.1134224071259,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,stroke_minf_to_0,NA,binary,count,831,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,stroke_minf_to_0,NA,binary,%,2.21617729418353,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,venous_thromboembolism_minf_to_0,NA,binary,count,1128,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,venous_thromboembolism_minf_to_0,NA,binary,%,3.00824065925274,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age_group,0 to 19,categorical,count,1279,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age_group,0 to 19,categorical,%,3.41093954183001,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age_group,20 to 39,categorical,count,4423,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age_group,20 to 39,categorical,%,11.7956103154919,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age_group,40 to 59,categorical,count,13796,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age_group,40 to 59,categorical,%,36.7922767154706,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age_group,60 to 79,categorical,count,15081,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age_group,60 to 79,categorical,%,40.219217537403,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age_group,80 to 150,categorical,count,2918,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,age_group,80 to 150,categorical,%,7.78195588980452,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,indication,covid,categorical,count,99,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,indication,covid,categorical,%,0.264021121689735,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,indication,malaria,categorical,count,<5,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,indication,malaria,categorical,%,0.00266688001706803,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,indication,multiple,categorical,count,101,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,indication,multiple,categorical,%,0.269354881723871,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,indication,none,categorical,count,18218,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,indication,none,categorical,%,48.5852201509454,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,indication,rheumatoid_arthritis,categorical,count,19078,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,indication,rheumatoid_arthritis,categorical,%,50.8787369656239,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,sex,Female,categorical,count,25891,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,sex,Female,categorical,%,69.0481905219084,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,sex,Male,categorical,count,11606,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,sex,Male,categorical,%,30.9518094780916,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,window,after_fda_retraction,categorical,count,15206,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,window,after_fda_retraction,categorical,%,40.5525775395365,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,window,before_pandemic,categorical,count,18770,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,window,before_pandemic,categorical,%,50.057337920367,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,window,during_hcq_use_for_covid,categorical,count,3521,PHARMETRICS
Cohort name,new_users_methotrexate,Overall,Overall,window,during_hcq_use_for_covid,categorical,%,9.39008454009654,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,number subjects,NA,NA,count,22836,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,number records,NA,NA,count,22836,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age,NA,numeric,median,57,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age,NA,numeric,q25,45,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age,NA,numeric,q75,66,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,future_observation,NA,numeric,median,244,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,future_observation,NA,numeric,q25,114,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,future_observation,NA,numeric,q75,427,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,prior_history,NA,numeric,median,1140,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,prior_history,NA,numeric,q25,602,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,prior_history,NA,numeric,q75,1509,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,cohort_end_date,NA,date,median,2021-10-08,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,cohort_end_date,NA,date,q25,2021-03-18,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,cohort_end_date,NA,date,q75,2022-03-11,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,cohort_start_date,NA,date,median,2021-05-28,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,cohort_start_date,NA,date,q25,2020-12-16,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,cohort_start_date,NA,date,q75,2021-10-27,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,6171,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,27.0231213872832,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,antibacterials_systemic_m365_to_0,NA,binary,count,14480,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,antibacterials_systemic_m365_to_0,NA,binary,%,63.4086530040287,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,antidepressants_m365_to_0,NA,binary,count,7933,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,antidepressants_m365_to_0,NA,binary,%,34.7390085829392,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,antiepileptics_m365_to_0,NA,binary,count,5131,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,antiepileptics_m365_to_0,NA,binary,%,22.468908740585,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,15841,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,69.3685409003328,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,antineoplastic_agents_m365_to_0,NA,binary,count,3513,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,antineoplastic_agents_m365_to_0,NA,binary,%,15.3836048344719,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,antithrombotics_m365_to_0,NA,binary,count,2633,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,antithrombotics_m365_to_0,NA,binary,%,11.5300402872657,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,anxiety_minf_to_0,NA,binary,count,7492,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,anxiety_minf_to_0,NA,binary,%,32.8078472587143,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,asthma_minf_to_0,NA,binary,count,3516,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,asthma_minf_to_0,NA,binary,%,15.3967419863374,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,beta_blocking_agents_m365_to_0,NA,binary,count,4618,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,beta_blocking_agents_m365_to_0,NA,binary,%,20.2224557715887,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,calicum_channel_blockers_m365_to_0,NA,binary,count,3540,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,calicum_channel_blockers_m365_to_0,NA,binary,%,15.5018392012612,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,chronic_kidney_disease_minf_to_0,NA,binary,count,2309,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,chronic_kidney_disease_minf_to_0,NA,binary,%,10.1112278857944,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,chronic_liver_disease_minf_to_0,NA,binary,count,2309,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,chronic_liver_disease_minf_to_0,NA,binary,%,10.1112278857944,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,copd_minf_to_0,NA,binary,count,2025,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,copd_minf_to_0,NA,binary,%,8.86757750919601,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,covid_minf_to_0,NA,binary,count,7942,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,covid_minf_to_0,NA,binary,%,34.7784200385356,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,dementia_minf_to_0,NA,binary,count,308,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,dementia_minf_to_0,NA,binary,%,1.34874759152216,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,depressive_disorder_minf_to_0,NA,binary,count,5670,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,depressive_disorder_minf_to_0,NA,binary,%,24.8292170257488,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,diabetes_minf_to_0,NA,binary,count,3597,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,diabetes_minf_to_0,NA,binary,%,15.7514450867052,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,diuretics_m365_to_0,NA,binary,count,4287,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,diuretics_m365_to_0,NA,binary,%,18.7729900157646,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,drugs_acid_related_disorder_m365_to_0,NA,binary,count,6446,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,drugs_acid_related_disorder_m365_to_0,NA,binary,%,28.2273603082852,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,7107,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,31.1219127693116,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,drugs_used_in_diabetes_m365_to_0,NA,binary,count,2985,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,drugs_used_in_diabetes_m365_to_0,NA,binary,%,13.0714661061482,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,gerd_minf_to_0,NA,binary,count,7014,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,gerd_minf_to_0,NA,binary,%,30.7146610614819,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,heart_failure_minf_to_0,NA,binary,count,1282,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,heart_failure_minf_to_0,NA,binary,%,5.61394289717989,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,hiv_minf_to_0,NA,binary,count,26,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,hiv_minf_to_0,NA,binary,%,0.113855316167455,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,1652,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,7.23419162725521,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,hypertension_minf_to_0,NA,binary,count,10858,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,hypertension_minf_to_0,NA,binary,%,47.5477316517779,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,hypothyroidism_minf_to_0,NA,binary,count,4875,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,hypothyroidism_minf_to_0,NA,binary,%,21.3478717813978,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,immunosupressants_m365_to_0,NA,binary,count,4240,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,immunosupressants_m365_to_0,NA,binary,%,18.5671746365388,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,infertility_minf_to_0,NA,binary,count,135,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,infertility_minf_to_0,NA,binary,%,0.5911718339464,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,inflammatory_bowel_disease_minf_to_0,NA,binary,count,371,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,inflammatory_bowel_disease_minf_to_0,NA,binary,%,1.62462778069714,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,lipid_modifying_agents_m365_to_0,NA,binary,count,6669,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,lipid_modifying_agents_m365_to_0,NA,binary,%,29.2038885969522,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,malaria_minf_to_0,NA,binary,count,5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,malaria_minf_to_0,NA,binary,%,0.0218952531091259,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,malignant_neoplastic_disease_minf_to_0,NA,binary,count,3060,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,malignant_neoplastic_disease_minf_to_0,NA,binary,%,13.3998949027851,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,myocardial_infarction_minf_to_0,NA,binary,count,392,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,myocardial_infarction_minf_to_0,NA,binary,%,1.71658784375547,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,opioids_m365_to_0,NA,binary,count,5832,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,opioids_m365_to_0,NA,binary,%,25.5386232264845,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,osteoporosis_minf_to_0,NA,binary,count,2175,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,osteoporosis_minf_to_0,NA,binary,%,9.52443510246978,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,pneumonia_minf_to_0,NA,binary,count,1903,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,pneumonia_minf_to_0,NA,binary,%,8.33333333333333,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,psycholeptics_m365_to_0,NA,binary,count,6733,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,psycholeptics_m365_to_0,NA,binary,%,29.484147836749,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,psychostimulants_m365_to_0,NA,binary,count,1051,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,psychostimulants_m365_to_0,NA,binary,%,4.60238220353827,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,rheumatoid_arthritis_minf_to_0,NA,binary,count,6503,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,rheumatoid_arthritis_minf_to_0,NA,binary,%,28.4769661937292,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,stroke_minf_to_0,NA,binary,count,562,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,stroke_minf_to_0,NA,binary,%,2.46102644946576,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,venous_thromboembolism_minf_to_0,NA,binary,count,685,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,venous_thromboembolism_minf_to_0,NA,binary,%,2.99964967595025,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age_group,0 to 19,categorical,count,340,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age_group,0 to 19,categorical,%,1.48887721142056,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age_group,20 to 39,categorical,count,3390,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age_group,20 to 39,categorical,%,14.8449816079874,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age_group,40 to 59,categorical,count,9294,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age_group,40 to 59,categorical,%,40.6988964792433,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age_group,60 to 79,categorical,count,8438,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age_group,60 to 79,categorical,%,36.9504291469609,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age_group,80 to 150,categorical,count,1374,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,age_group,80 to 150,categorical,%,6.01681555438781,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,indication,covid,categorical,count,2166,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,indication,covid,categorical,%,9.48502364687336,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,indication,malaria,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,indication,malaria,categorical,%,0.0175162024873008,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,indication,multiple,categorical,count,140,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,indication,multiple,categorical,%,0.613067087055526,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,indication,none,categorical,count,14163,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,indication,none,categorical,%,62.0204939569101,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,indication,rheumatoid_arthritis,categorical,count,6363,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,indication,rheumatoid_arthritis,categorical,%,27.8638991066737,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,sex,Female,categorical,count,16471,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,sex,Female,categorical,%,72.1273427920827,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,sex,Male,categorical,count,6365,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,sex,Male,categorical,%,27.8726572079173,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,window,after_fda_retraction,categorical,count,22836,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,window,after_fda_retraction,categorical,%,100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,window,before_pandemic,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,window,before_pandemic,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,window,during_hcq_use_for_covid,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,after_fda_retraction,window,during_hcq_use_for_covid,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,number subjects,NA,NA,count,17245,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,number records,NA,NA,count,17245,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age,NA,numeric,median,56,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age,NA,numeric,q25,45,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age,NA,numeric,q75,65,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,future_observation,NA,numeric,median,749,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,future_observation,NA,numeric,q25,279,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,future_observation,NA,numeric,q75,1084,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,prior_history,NA,numeric,median,730,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,prior_history,NA,numeric,q25,730,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,prior_history,NA,numeric,q75,866,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,cohort_end_date,NA,date,median,2019-10-08,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,cohort_end_date,NA,date,q25,2019-05-08,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,cohort_end_date,NA,date,q75,2020-04-14,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,cohort_start_date,NA,date,median,2019-03-07,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,cohort_start_date,NA,date,q25,2019-01-01,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,cohort_start_date,NA,date,q75,2019-08-13,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,4965,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,28.7909538996811,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,antibacterials_systemic_m365_to_0,NA,binary,count,10587,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,antibacterials_systemic_m365_to_0,NA,binary,%,61.3917077413743,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,antidepressants_m365_to_0,NA,binary,count,6008,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,antidepressants_m365_to_0,NA,binary,%,34.8390837924036,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,antiepileptics_m365_to_0,NA,binary,count,4444,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,antiepileptics_m365_to_0,NA,binary,%,25.7697883444477,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,12625,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,73.2096259785445,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,antineoplastic_agents_m365_to_0,NA,binary,count,3953,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,antineoplastic_agents_m365_to_0,NA,binary,%,22.9225862568861,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,antithrombotics_m365_to_0,NA,binary,count,2124,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,antithrombotics_m365_to_0,NA,binary,%,12.3166135111627,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,anxiety_minf_to_0,NA,binary,count,4763,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,anxiety_minf_to_0,NA,binary,%,27.6195998840244,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,asthma_minf_to_0,NA,binary,count,2740,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,asthma_minf_to_0,NA,binary,%,15.8886633806901,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,beta_blocking_agents_m365_to_0,NA,binary,count,3677,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,beta_blocking_agents_m365_to_0,NA,binary,%,21.3221223543056,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,calicum_channel_blockers_m365_to_0,NA,binary,count,2958,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,calicum_channel_blockers_m365_to_0,NA,binary,%,17.1527979124384,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,chronic_kidney_disease_minf_to_0,NA,binary,count,1876,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,chronic_kidney_disease_minf_to_0,NA,binary,%,10.8785155117425,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,chronic_liver_disease_minf_to_0,NA,binary,count,1876,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,chronic_liver_disease_minf_to_0,NA,binary,%,10.8785155117425,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,copd_minf_to_0,NA,binary,count,1367,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,copd_minf_to_0,NA,binary,%,7.92693534357785,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,covid_minf_to_0,NA,binary,count,1102,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,covid_minf_to_0,NA,binary,%,6.39025804581038,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,dementia_minf_to_0,NA,binary,count,197,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,dementia_minf_to_0,NA,binary,%,1.14236010437808,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,depressive_disorder_minf_to_0,NA,binary,count,4012,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,depressive_disorder_minf_to_0,NA,binary,%,23.2647144099739,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,diabetes_minf_to_0,NA,binary,count,2626,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,diabetes_minf_to_0,NA,binary,%,15.2276022035373,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,diuretics_m365_to_0,NA,binary,count,3442,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,diuretics_m365_to_0,NA,binary,%,19.9594085242099,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,drugs_acid_related_disorder_m365_to_0,NA,binary,count,5323,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,drugs_acid_related_disorder_m365_to_0,NA,binary,%,30.8669179472311,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,5117,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,29.6723688025515,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,drugs_used_in_diabetes_m365_to_0,NA,binary,count,2113,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,drugs_used_in_diabetes_m365_to_0,NA,binary,%,12.2528269063497,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,gerd_minf_to_0,NA,binary,count,5006,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,gerd_minf_to_0,NA,binary,%,29.0287039721658,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,heart_failure_minf_to_0,NA,binary,count,947,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,heart_failure_minf_to_0,NA,binary,%,5.4914467961728,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,hiv_minf_to_0,NA,binary,count,24,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,hiv_minf_to_0,NA,binary,%,0.139170774137431,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,1523,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,8.83154537547115,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,hypertension_minf_to_0,NA,binary,count,8294,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,hypertension_minf_to_0,NA,binary,%,48.0951000289939,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,hypothyroidism_minf_to_0,NA,binary,count,3818,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,hypothyroidism_minf_to_0,NA,binary,%,22.139750652363,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,immunosupressants_m365_to_0,NA,binary,count,5107,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,immunosupressants_m365_to_0,NA,binary,%,29.6143809799942,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,infertility_minf_to_0,NA,binary,count,113,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,infertility_minf_to_0,NA,binary,%,0.655262394897072,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,inflammatory_bowel_disease_minf_to_0,NA,binary,count,282,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,inflammatory_bowel_disease_minf_to_0,NA,binary,%,1.63525659611482,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,lipid_modifying_agents_m365_to_0,NA,binary,count,4766,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,lipid_modifying_agents_m365_to_0,NA,binary,%,27.6369962307915,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,malaria_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,malaria_minf_to_0,NA,binary,%,0.0173963467671789,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,malignant_neoplastic_disease_minf_to_0,NA,binary,count,1965,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,malignant_neoplastic_disease_minf_to_0,NA,binary,%,11.3946071325022,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,myocardial_infarction_minf_to_0,NA,binary,count,226,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,myocardial_infarction_minf_to_0,NA,binary,%,1.31052478979414,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,opioids_m365_to_0,NA,binary,count,5610,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,opioids_m365_to_0,NA,binary,%,32.5311684546245,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,osteoporosis_minf_to_0,NA,binary,count,1962,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,osteoporosis_minf_to_0,NA,binary,%,11.377210785735,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,pneumonia_minf_to_0,NA,binary,count,1260,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,pneumonia_minf_to_0,NA,binary,%,7.30646564221513,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,psycholeptics_m365_to_0,NA,binary,count,5012,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,psycholeptics_m365_to_0,NA,binary,%,29.0634966657002,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,psychostimulants_m365_to_0,NA,binary,count,666,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,psychostimulants_m365_to_0,NA,binary,%,3.86198898231371,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,rheumatoid_arthritis_minf_to_0,NA,binary,count,6963,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,rheumatoid_arthritis_minf_to_0,NA,binary,%,40.3769208466222,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,stroke_minf_to_0,NA,binary,count,365,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,stroke_minf_to_0,NA,binary,%,2.1165555233401,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,venous_thromboembolism_minf_to_0,NA,binary,count,553,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,venous_thromboembolism_minf_to_0,NA,binary,%,3.20672658741664,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age_group,0 to 19,categorical,count,238,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age_group,0 to 19,categorical,%,1.38011017686286,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age_group,20 to 39,categorical,count,2531,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age_group,20 to 39,categorical,%,14.6767178892433,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age_group,40 to 59,categorical,count,7332,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age_group,40 to 59,categorical,%,42.5166714989852,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age_group,60 to 79,categorical,count,6141,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age_group,60 to 79,categorical,%,35.6103218324152,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age_group,80 to 150,categorical,count,1003,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,age_group,80 to 150,categorical,%,5.81617860249348,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,indication,covid,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,indication,covid,categorical,%,0.0057987822557263,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,indication,malaria,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,indication,malaria,categorical,%,0.0115975645114526,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,indication,multiple,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,indication,multiple,categorical,%,0.0057987822557263,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,indication,none,categorical,count,10269,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,indication,none,categorical,%,59.5476949840534,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,indication,rheumatoid_arthritis,categorical,count,6972,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,indication,rheumatoid_arthritis,categorical,%,40.4291098869237,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,sex,Female,categorical,count,14130,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,sex,Female,categorical,%,81.9367932734126,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,sex,Male,categorical,count,3115,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,sex,Male,categorical,%,18.0632067265874,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,window,before_pandemic,categorical,count,17245,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,window,before_pandemic,categorical,%,100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,window,after_fda_retraction,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,window,after_fda_retraction,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,window,during_hcq_use_for_covid,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,before_pandemic,window,during_hcq_use_for_covid,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,number subjects,NA,NA,count,9565,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,number records,NA,NA,count,9565,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age,NA,numeric,median,56,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age,NA,numeric,q25,44,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age,NA,numeric,q75,65,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,future_observation,NA,numeric,median,717,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,future_observation,NA,numeric,q25,287,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,future_observation,NA,numeric,q75,742,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,prior_history,NA,numeric,median,1170,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,prior_history,NA,numeric,q25,704,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,prior_history,NA,numeric,q75,1176,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,cohort_end_date,NA,date,median,2020-04-18,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,cohort_end_date,NA,date,q25,2020-04-03,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,cohort_end_date,NA,date,q75,2020-06-16,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,cohort_start_date,NA,date,median,2020-03-20,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,cohort_start_date,NA,date,q25,2020-03-18,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,cohort_start_date,NA,date,q75,2020-04-03,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,2233,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,23.3455305802405,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,antibacterials_systemic_m365_to_0,NA,binary,count,6655,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,antibacterials_systemic_m365_to_0,NA,binary,%,69.5765812859383,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,antidepressants_m365_to_0,NA,binary,count,2423,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,antidepressants_m365_to_0,NA,binary,%,25.3319393622582,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,antiepileptics_m365_to_0,NA,binary,count,1602,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,antiepileptics_m365_to_0,NA,binary,%,16.7485624673288,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,5035,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,52.639832723471,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,antineoplastic_agents_m365_to_0,NA,binary,count,1018,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,antineoplastic_agents_m365_to_0,NA,binary,%,10.64296915839,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,antithrombotics_m365_to_0,NA,binary,count,892,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,antithrombotics_m365_to_0,NA,binary,%,9.32566649242028,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,anxiety_minf_to_0,NA,binary,count,2263,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,anxiety_minf_to_0,NA,binary,%,23.659174072138,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,asthma_minf_to_0,NA,binary,count,1258,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,asthma_minf_to_0,NA,binary,%,13.1521170935703,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,beta_blocking_agents_m365_to_0,NA,binary,count,1609,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,beta_blocking_agents_m365_to_0,NA,binary,%,16.8217459487716,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,calicum_channel_blockers_m365_to_0,NA,binary,count,1270,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,calicum_channel_blockers_m365_to_0,NA,binary,%,13.2775744903293,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,chronic_kidney_disease_minf_to_0,NA,binary,count,755,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,chronic_kidney_disease_minf_to_0,NA,binary,%,7.89336121275484,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,chronic_liver_disease_minf_to_0,NA,binary,count,755,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,chronic_liver_disease_minf_to_0,NA,binary,%,7.89336121275484,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,copd_minf_to_0,NA,binary,count,541,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,copd_minf_to_0,NA,binary,%,5.65603763721903,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,covid_minf_to_0,NA,binary,count,1230,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,covid_minf_to_0,NA,binary,%,12.8593831677993,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,dementia_minf_to_0,NA,binary,count,159,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,dementia_minf_to_0,NA,binary,%,1.66231050705698,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,depressive_disorder_minf_to_0,NA,binary,count,1649,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,depressive_disorder_minf_to_0,NA,binary,%,17.2399372713016,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,diabetes_minf_to_0,NA,binary,count,1252,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,diabetes_minf_to_0,NA,binary,%,13.0893883951908,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,diuretics_m365_to_0,NA,binary,count,1420,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,diuretics_m365_to_0,NA,binary,%,14.845791949817,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,drugs_acid_related_disorder_m365_to_0,NA,binary,count,2039,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,drugs_acid_related_disorder_m365_to_0,NA,binary,%,21.3173026659697,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,2571,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,26.8792472556194,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,drugs_used_in_diabetes_m365_to_0,NA,binary,count,1127,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,drugs_used_in_diabetes_m365_to_0,NA,binary,%,11.7825405122844,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,gerd_minf_to_0,NA,binary,count,2269,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,gerd_minf_to_0,NA,binary,%,23.7219027705175,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,heart_failure_minf_to_0,NA,binary,count,408,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,heart_failure_minf_to_0,NA,binary,%,4.26555148980659,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,hiv_minf_to_0,NA,binary,count,12,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,hiv_minf_to_0,NA,binary,%,0.125457396759017,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,679,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,7.09879769994773,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,hypertension_minf_to_0,NA,binary,count,3709,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,hypertension_minf_to_0,NA,binary,%,38.7767903815996,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,hypothyroidism_minf_to_0,NA,binary,count,1696,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,hypothyroidism_minf_to_0,NA,binary,%,17.7313120752744,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,immunosupressants_m365_to_0,NA,binary,count,1255,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,immunosupressants_m365_to_0,NA,binary,%,13.1207527443806,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,infertility_minf_to_0,NA,binary,count,51,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,infertility_minf_to_0,NA,binary,%,0.533193936225823,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,inflammatory_bowel_disease_minf_to_0,NA,binary,count,145,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,inflammatory_bowel_disease_minf_to_0,NA,binary,%,1.51594354417146,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,lipid_modifying_agents_m365_to_0,NA,binary,count,2511,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,lipid_modifying_agents_m365_to_0,NA,binary,%,26.2519602718244,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,malaria_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,malaria_minf_to_0,NA,binary,%,0.0104547830632514,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,malignant_neoplastic_disease_minf_to_0,NA,binary,count,1276,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,malignant_neoplastic_disease_minf_to_0,NA,binary,%,13.3403031887088,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,myocardial_infarction_minf_to_0,NA,binary,count,116,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,myocardial_infarction_minf_to_0,NA,binary,%,1.21275483533717,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,opioids_m365_to_0,NA,binary,count,2136,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,opioids_m365_to_0,NA,binary,%,22.3314166231051,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,osteoporosis_minf_to_0,NA,binary,count,761,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,osteoporosis_minf_to_0,NA,binary,%,7.95608991113434,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,pneumonia_minf_to_0,NA,binary,count,798,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,pneumonia_minf_to_0,NA,binary,%,8.34291688447465,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,psycholeptics_m365_to_0,NA,binary,count,2450,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,psycholeptics_m365_to_0,NA,binary,%,25.614218504966,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,psychostimulants_m365_to_0,NA,binary,count,423,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,psychostimulants_m365_to_0,NA,binary,%,4.42237323575536,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,rheumatoid_arthritis_minf_to_0,NA,binary,count,1714,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,rheumatoid_arthritis_minf_to_0,NA,binary,%,17.919498170413,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,stroke_minf_to_0,NA,binary,count,191,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,stroke_minf_to_0,NA,binary,%,1.99686356508102,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,venous_thromboembolism_minf_to_0,NA,binary,count,229,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,venous_thromboembolism_minf_to_0,NA,binary,%,2.39414532148458,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age_group,0 to 19,categorical,count,207,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age_group,0 to 19,categorical,%,2.16414009409305,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age_group,20 to 39,categorical,count,1517,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age_group,20 to 39,categorical,%,15.8599059069524,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age_group,40 to 59,categorical,count,4068,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age_group,40 to 59,categorical,%,42.5300575013068,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age_group,60 to 79,categorical,count,3213,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age_group,60 to 79,categorical,%,33.5912179822269,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age_group,80 to 150,categorical,count,560,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,age_group,80 to 150,categorical,%,5.85467851542081,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,indication,covid,categorical,count,382,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,indication,covid,categorical,%,3.99372713016205,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,indication,malaria,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,indication,malaria,categorical,%,0.0104547830632514,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,indication,multiple,categorical,count,11,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,indication,multiple,categorical,%,0.115002613695766,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,indication,none,categorical,count,7467,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,indication,none,categorical,%,78.0658651332985,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,indication,rheumatoid_arthritis,categorical,count,1704,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,indication,rheumatoid_arthritis,categorical,%,17.8149503397804,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,sex,Female,categorical,count,6063,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,sex,Female,categorical,%,63.3873497124935,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,sex,Male,categorical,count,3502,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,sex,Male,categorical,%,36.6126502875065,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,window,during_hcq_use_for_covid,categorical,count,9565,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,window,during_hcq_use_for_covid,categorical,%,100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,window,before_pandemic,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,window,before_pandemic,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,window,after_fda_retraction,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Calendar time,during_hcq_use_for_covid,window,after_fda_retraction,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,number subjects,NA,NA,count,2549,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,number records,NA,NA,count,2549,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age,NA,numeric,median,54,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age,NA,numeric,q25,42,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age,NA,numeric,q75,63,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,future_observation,NA,numeric,median,217,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,future_observation,NA,numeric,q25,93,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,future_observation,NA,numeric,q75,455,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,prior_history,NA,numeric,median,1202,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,prior_history,NA,numeric,q25,741,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,prior_history,NA,numeric,q75,1492,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,cohort_end_date,NA,date,median,2021-05-22,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,cohort_end_date,NA,date,q25,2020-10-26,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,cohort_end_date,NA,date,q75,2021-11-20,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,cohort_start_date,NA,date,median,2021-04-15,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,cohort_start_date,NA,date,q25,2020-10-19,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,cohort_start_date,NA,date,q75,2021-10-23,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,700,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,27.461749705767,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,antibacterials_systemic_m365_to_0,NA,binary,count,2192,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,antibacterials_systemic_m365_to_0,NA,binary,%,85.9945076500588,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,antidepressants_m365_to_0,NA,binary,count,643,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,antidepressants_m365_to_0,NA,binary,%,25.2255786582974,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,antiepileptics_m365_to_0,NA,binary,count,370,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,antiepileptics_m365_to_0,NA,binary,%,14.5154962730483,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,1832,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,71.871322087093,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,antineoplastic_agents_m365_to_0,NA,binary,count,84,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,antineoplastic_agents_m365_to_0,NA,binary,%,3.29540996469204,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,antithrombotics_m365_to_0,NA,binary,count,273,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,antithrombotics_m365_to_0,NA,binary,%,10.7100823852491,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,anxiety_minf_to_0,NA,binary,count,723,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,anxiety_minf_to_0,NA,binary,%,28.3640643389565,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,asthma_minf_to_0,NA,binary,count,368,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,asthma_minf_to_0,NA,binary,%,14.4370341310318,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,beta_blocking_agents_m365_to_0,NA,binary,count,469,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,beta_blocking_agents_m365_to_0,NA,binary,%,18.3993723028639,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,calicum_channel_blockers_m365_to_0,NA,binary,count,348,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,calicum_channel_blockers_m365_to_0,NA,binary,%,13.652412710867,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,chronic_kidney_disease_minf_to_0,NA,binary,count,204,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,chronic_kidney_disease_minf_to_0,NA,binary,%,8.00313848568066,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,chronic_liver_disease_minf_to_0,NA,binary,count,204,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,chronic_liver_disease_minf_to_0,NA,binary,%,8.00313848568066,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,copd_minf_to_0,NA,binary,count,169,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,copd_minf_to_0,NA,binary,%,6.63005100039231,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,covid_minf_to_0,NA,binary,count,2549,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,covid_minf_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,dementia_minf_to_0,NA,binary,count,53,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,dementia_minf_to_0,NA,binary,%,2.07924676343664,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,depressive_disorder_minf_to_0,NA,binary,count,478,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,depressive_disorder_minf_to_0,NA,binary,%,18.752451941938,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,diabetes_minf_to_0,NA,binary,count,504,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,diabetes_minf_to_0,NA,binary,%,19.7724597881522,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,diuretics_m365_to_0,NA,binary,count,373,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,diuretics_m365_to_0,NA,binary,%,14.633189486073,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,drugs_acid_related_disorder_m365_to_0,NA,binary,count,617,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,drugs_acid_related_disorder_m365_to_0,NA,binary,%,24.2055708120832,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,1145,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,44.9195763044331,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,drugs_used_in_diabetes_m365_to_0,NA,binary,count,423,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,drugs_used_in_diabetes_m365_to_0,NA,binary,%,16.5947430364849,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,gerd_minf_to_0,NA,binary,count,710,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,gerd_minf_to_0,NA,binary,%,27.8540604158494,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,heart_failure_minf_to_0,NA,binary,count,129,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,heart_failure_minf_to_0,NA,binary,%,5.06080816006277,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,hiv_minf_to_0,NA,binary,count,5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,hiv_minf_to_0,NA,binary,%,0.196155355041193,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,156,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,6.12004707728521,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,hypertension_minf_to_0,NA,binary,count,1222,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,hypertension_minf_to_0,NA,binary,%,47.9403687720675,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,hypothyroidism_minf_to_0,NA,binary,count,403,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,hypothyroidism_minf_to_0,NA,binary,%,15.8101216163201,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,immunosupressants_m365_to_0,NA,binary,count,71,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,immunosupressants_m365_to_0,NA,binary,%,2.78540604158494,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,infertility_minf_to_0,NA,binary,count,8,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,infertility_minf_to_0,NA,binary,%,0.313848568065908,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,inflammatory_bowel_disease_minf_to_0,NA,binary,count,29,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,inflammatory_bowel_disease_minf_to_0,NA,binary,%,1.13770105923892,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,lipid_modifying_agents_m365_to_0,NA,binary,count,762,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,lipid_modifying_agents_m365_to_0,NA,binary,%,29.8940761082778,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,malaria_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,malaria_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,malignant_neoplastic_disease_minf_to_0,NA,binary,count,274,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,malignant_neoplastic_disease_minf_to_0,NA,binary,%,10.7493134562574,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,myocardial_infarction_minf_to_0,NA,binary,count,51,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,myocardial_infarction_minf_to_0,NA,binary,%,2.00078462142016,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,opioids_m365_to_0,NA,binary,count,575,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,opioids_m365_to_0,NA,binary,%,22.5578658297372,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,osteoporosis_minf_to_0,NA,binary,count,101,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,osteoporosis_minf_to_0,NA,binary,%,3.96233817183209,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,pneumonia_minf_to_0,NA,binary,count,568,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,pneumonia_minf_to_0,NA,binary,%,22.2832483326795,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,psycholeptics_m365_to_0,NA,binary,count,612,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,psycholeptics_m365_to_0,NA,binary,%,24.009415457042,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,psychostimulants_m365_to_0,NA,binary,count,99,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,psychostimulants_m365_to_0,NA,binary,%,3.88387602981561,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,rheumatoid_arthritis_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,rheumatoid_arthritis_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,stroke_minf_to_0,NA,binary,count,58,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,stroke_minf_to_0,NA,binary,%,2.27540211847783,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,venous_thromboembolism_minf_to_0,NA,binary,count,55,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,venous_thromboembolism_minf_to_0,NA,binary,%,2.15770890545312,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age_group,0 to 19,categorical,count,56,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age_group,0 to 19,categorical,%,2.19693997646136,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age_group,20 to 39,categorical,count,457,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age_group,20 to 39,categorical,%,17.928599450765,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age_group,40 to 59,categorical,count,1164,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age_group,40 to 59,categorical,%,45.6649666535896,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age_group,60 to 79,categorical,count,728,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age_group,60 to 79,categorical,%,28.5602196939976,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age_group,80 to 150,categorical,count,144,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,age_group,80 to 150,categorical,%,5.64927422518635,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,indication,covid,categorical,count,2549,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,indication,covid,categorical,%,100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,indication,none,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,indication,none,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,indication,rheumatoid_arthritis,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,indication,rheumatoid_arthritis,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,indication,multiple,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,indication,multiple,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,indication,malaria,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,indication,malaria,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,sex,Female,categorical,count,1336,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,sex,Female,categorical,%,52.4127108670067,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,sex,Male,categorical,count,1213,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,sex,Male,categorical,%,47.5872891329933,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,window,after_fda_retraction,categorical,count,2166,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,window,after_fda_retraction,categorical,%,84.9744998038447,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,window,before_pandemic,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,window,before_pandemic,categorical,%,0.0392310710082385,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,window,during_hcq_use_for_covid,categorical,count,382,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,covid,window,during_hcq_use_for_covid,categorical,%,14.9862691251471,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,number subjects,NA,NA,count,7,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,number records,NA,NA,count,7,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,age,NA,numeric,median,55,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,age,NA,numeric,q25,34,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,age,NA,numeric,q75,65.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,future_observation,NA,numeric,median,526,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,future_observation,NA,numeric,q25,285.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,future_observation,NA,numeric,q75,792,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,prior_history,NA,numeric,median,967,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,prior_history,NA,numeric,q25,782.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,prior_history,NA,numeric,q75,1275.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,cohort_end_date,NA,date,median,2020-12-01,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,cohort_end_date,NA,date,q25,2020-08-30,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,cohort_end_date,NA,date,q75,2022-03-18,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,cohort_start_date,NA,date,median,2020-10-21,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,cohort_start_date,NA,date,q25,2020-01-29,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,cohort_start_date,NA,date,q75,2021-06-18,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,42.8571428571429,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,antibacterials_systemic_m365_to_0,NA,binary,count,6,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,antibacterials_systemic_m365_to_0,NA,binary,%,85.7142857142857,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,antidepressants_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,antidepressants_m365_to_0,NA,binary,%,28.5714285714286,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,antiepileptics_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,antiepileptics_m365_to_0,NA,binary,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,71.4285714285714,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,antineoplastic_agents_m365_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,antineoplastic_agents_m365_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,antithrombotics_m365_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,antithrombotics_m365_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,anxiety_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,anxiety_minf_to_0,NA,binary,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,asthma_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,asthma_minf_to_0,NA,binary,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,beta_blocking_agents_m365_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,beta_blocking_agents_m365_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,calicum_channel_blockers_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,calicum_channel_blockers_m365_to_0,NA,binary,%,28.5714285714286,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,chronic_kidney_disease_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,chronic_kidney_disease_minf_to_0,NA,binary,%,28.5714285714286,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,chronic_liver_disease_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,chronic_liver_disease_minf_to_0,NA,binary,%,28.5714285714286,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,copd_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,copd_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,covid_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,covid_minf_to_0,NA,binary,%,28.5714285714286,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,dementia_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,dementia_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,depressive_disorder_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,depressive_disorder_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,diabetes_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,diabetes_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,diuretics_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,diuretics_m365_to_0,NA,binary,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,drugs_acid_related_disorder_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,drugs_acid_related_disorder_m365_to_0,NA,binary,%,28.5714285714286,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,28.5714285714286,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,drugs_used_in_diabetes_m365_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,drugs_used_in_diabetes_m365_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,gerd_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,gerd_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,heart_failure_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,heart_failure_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,hiv_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,hiv_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,hypertension_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,hypertension_minf_to_0,NA,binary,%,57.1428571428571,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,hypothyroidism_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,hypothyroidism_minf_to_0,NA,binary,%,28.5714285714286,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,immunosupressants_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,immunosupressants_m365_to_0,NA,binary,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,infertility_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,infertility_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,inflammatory_bowel_disease_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,inflammatory_bowel_disease_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,lipid_modifying_agents_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,lipid_modifying_agents_m365_to_0,NA,binary,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,malaria_minf_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,malaria_minf_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,malignant_neoplastic_disease_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,malignant_neoplastic_disease_minf_to_0,NA,binary,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,myocardial_infarction_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,myocardial_infarction_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,opioids_m365_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,opioids_m365_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,osteoporosis_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,osteoporosis_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,pneumonia_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,pneumonia_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,psycholeptics_m365_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,psycholeptics_m365_to_0,NA,binary,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,psychostimulants_m365_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,psychostimulants_m365_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,rheumatoid_arthritis_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,rheumatoid_arthritis_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,stroke_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,stroke_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,venous_thromboembolism_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,venous_thromboembolism_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,age_group,0 to 19,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,age_group,0 to 19,categorical,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,age_group,20 to 39,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,age_group,20 to 39,categorical,%,28.5714285714286,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,age_group,40 to 59,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,age_group,40 to 59,categorical,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,age_group,60 to 79,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,age_group,60 to 79,categorical,%,42.8571428571429,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,age_group,80 to 150,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,age_group,80 to 150,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,indication,malaria,categorical,count,7,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,indication,malaria,categorical,%,100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,indication,none,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,indication,none,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,indication,rheumatoid_arthritis,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,indication,rheumatoid_arthritis,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,indication,covid,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,indication,covid,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,indication,multiple,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,indication,multiple,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,sex,Female,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,sex,Female,categorical,%,57.1428571428571,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,sex,Male,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,sex,Male,categorical,%,42.8571428571429,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,window,after_fda_retraction,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,window,after_fda_retraction,categorical,%,57.1428571428571,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,window,before_pandemic,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,window,before_pandemic,categorical,%,28.5714285714286,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,window,during_hcq_use_for_covid,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,malaria,window,during_hcq_use_for_covid,categorical,%,14.2857142857143,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,number subjects,NA,NA,count,152,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,number records,NA,NA,count,152,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age,NA,numeric,median,60,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age,NA,numeric,q25,49.75,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age,NA,numeric,q75,70,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,future_observation,NA,numeric,median,177.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,future_observation,NA,numeric,q25,64.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,future_observation,NA,numeric,q75,412,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,prior_history,NA,numeric,median,1120,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,prior_history,NA,numeric,q25,705,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,prior_history,NA,numeric,q75,1526.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,cohort_end_date,NA,date,median,2021-12-07,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,cohort_end_date,NA,date,q25,2021-04-20,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,cohort_end_date,NA,date,q75,2022-04-02,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,cohort_start_date,NA,date,median,2021-08-25,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,cohort_start_date,NA,date,q25,2021-01-13,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,cohort_start_date,NA,date,q75,2022-01-18,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,52,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,34.2105263157895,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,antibacterials_systemic_m365_to_0,NA,binary,count,133,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,antibacterials_systemic_m365_to_0,NA,binary,%,87.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,antidepressants_m365_to_0,NA,binary,count,71,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,antidepressants_m365_to_0,NA,binary,%,46.7105263157895,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,antiepileptics_m365_to_0,NA,binary,count,56,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,antiepileptics_m365_to_0,NA,binary,%,36.8421052631579,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,131,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,86.1842105263158,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,antineoplastic_agents_m365_to_0,NA,binary,count,55,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,antineoplastic_agents_m365_to_0,NA,binary,%,36.1842105263158,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,antithrombotics_m365_to_0,NA,binary,count,42,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,antithrombotics_m365_to_0,NA,binary,%,27.6315789473684,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,anxiety_minf_to_0,NA,binary,count,64,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,anxiety_minf_to_0,NA,binary,%,42.1052631578947,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,asthma_minf_to_0,NA,binary,count,42,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,asthma_minf_to_0,NA,binary,%,27.6315789473684,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,beta_blocking_agents_m365_to_0,NA,binary,count,46,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,beta_blocking_agents_m365_to_0,NA,binary,%,30.2631578947368,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,calicum_channel_blockers_m365_to_0,NA,binary,count,42,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,calicum_channel_blockers_m365_to_0,NA,binary,%,27.6315789473684,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,chronic_kidney_disease_minf_to_0,NA,binary,count,29,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,chronic_kidney_disease_minf_to_0,NA,binary,%,19.0789473684211,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,chronic_liver_disease_minf_to_0,NA,binary,count,29,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,chronic_liver_disease_minf_to_0,NA,binary,%,19.0789473684211,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,copd_minf_to_0,NA,binary,count,36,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,copd_minf_to_0,NA,binary,%,23.6842105263158,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,covid_minf_to_0,NA,binary,count,151,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,covid_minf_to_0,NA,binary,%,99.3421052631579,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,dementia_minf_to_0,NA,binary,count,10,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,dementia_minf_to_0,NA,binary,%,6.57894736842105,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,depressive_disorder_minf_to_0,NA,binary,count,59,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,depressive_disorder_minf_to_0,NA,binary,%,38.8157894736842,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,diabetes_minf_to_0,NA,binary,count,37,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,diabetes_minf_to_0,NA,binary,%,24.3421052631579,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,diuretics_m365_to_0,NA,binary,count,48,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,diuretics_m365_to_0,NA,binary,%,31.5789473684211,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,drugs_acid_related_disorder_m365_to_0,NA,binary,count,68,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,drugs_acid_related_disorder_m365_to_0,NA,binary,%,44.7368421052632,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,78,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,51.3157894736842,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,drugs_used_in_diabetes_m365_to_0,NA,binary,count,24,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,drugs_used_in_diabetes_m365_to_0,NA,binary,%,15.7894736842105,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,gerd_minf_to_0,NA,binary,count,82,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,gerd_minf_to_0,NA,binary,%,53.9473684210526,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,heart_failure_minf_to_0,NA,binary,count,26,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,heart_failure_minf_to_0,NA,binary,%,17.1052631578947,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,hiv_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,hiv_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,9,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,5.92105263157895,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,hypertension_minf_to_0,NA,binary,count,101,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,hypertension_minf_to_0,NA,binary,%,66.4473684210526,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,hypothyroidism_minf_to_0,NA,binary,count,41,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,hypothyroidism_minf_to_0,NA,binary,%,26.9736842105263,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,immunosupressants_m365_to_0,NA,binary,count,65,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,immunosupressants_m365_to_0,NA,binary,%,42.7631578947368,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,infertility_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,infertility_minf_to_0,NA,binary,%,0.657894736842105,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,inflammatory_bowel_disease_minf_to_0,NA,binary,count,5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,inflammatory_bowel_disease_minf_to_0,NA,binary,%,3.28947368421053,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,lipid_modifying_agents_m365_to_0,NA,binary,count,53,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,lipid_modifying_agents_m365_to_0,NA,binary,%,34.8684210526316,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,malaria_minf_to_0,NA,binary,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,malaria_minf_to_0,NA,binary,%,1.31578947368421,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,malignant_neoplastic_disease_minf_to_0,NA,binary,count,25,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,malignant_neoplastic_disease_minf_to_0,NA,binary,%,16.4473684210526,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,myocardial_infarction_minf_to_0,NA,binary,count,7,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,myocardial_infarction_minf_to_0,NA,binary,%,4.60526315789474,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,opioids_m365_to_0,NA,binary,count,58,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,opioids_m365_to_0,NA,binary,%,38.1578947368421,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,osteoporosis_minf_to_0,NA,binary,count,19,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,osteoporosis_minf_to_0,NA,binary,%,12.5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,pneumonia_minf_to_0,NA,binary,count,54,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,pneumonia_minf_to_0,NA,binary,%,35.5263157894737,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,psycholeptics_m365_to_0,NA,binary,count,58,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,psycholeptics_m365_to_0,NA,binary,%,38.1578947368421,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,psychostimulants_m365_to_0,NA,binary,count,8,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,psychostimulants_m365_to_0,NA,binary,%,5.26315789473684,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,rheumatoid_arthritis_minf_to_0,NA,binary,count,152,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,rheumatoid_arthritis_minf_to_0,NA,binary,%,100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,stroke_minf_to_0,NA,binary,count,6,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,stroke_minf_to_0,NA,binary,%,3.94736842105263,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,venous_thromboembolism_minf_to_0,NA,binary,count,17,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,venous_thromboembolism_minf_to_0,NA,binary,%,11.1842105263158,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age_group,20 to 39,categorical,count,10,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age_group,20 to 39,categorical,%,6.57894736842105,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age_group,40 to 59,categorical,count,64,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age_group,40 to 59,categorical,%,42.1052631578947,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age_group,60 to 79,categorical,count,60,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age_group,60 to 79,categorical,%,39.4736842105263,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age_group,80 to 150,categorical,count,18,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age_group,80 to 150,categorical,%,11.8421052631579,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age_group,0 to 19,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,age_group,0 to 19,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,indication,multiple,categorical,count,152,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,indication,multiple,categorical,%,100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,indication,none,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,indication,none,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,indication,rheumatoid_arthritis,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,indication,rheumatoid_arthritis,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,indication,covid,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,indication,covid,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,indication,malaria,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,indication,malaria,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,sex,Female,categorical,count,118,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,sex,Female,categorical,%,77.6315789473684,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,sex,Male,categorical,count,34,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,sex,Male,categorical,%,22.3684210526316,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,window,after_fda_retraction,categorical,count,140,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,window,after_fda_retraction,categorical,%,92.1052631578947,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,window,before_pandemic,categorical,count,<5,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,window,before_pandemic,categorical,%,0.657894736842105,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,window,during_hcq_use_for_covid,categorical,count,11,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,multiple,window,during_hcq_use_for_covid,categorical,%,7.23684210526316,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,number subjects,NA,NA,count,31899,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,number records,NA,NA,count,31899,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age,NA,numeric,median,54,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age,NA,numeric,q25,43,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age,NA,numeric,q75,64,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,future_observation,NA,numeric,median,401,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,future_observation,NA,numeric,q25,167,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,future_observation,NA,numeric,q75,738,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,prior_history,NA,numeric,median,887,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,prior_history,NA,numeric,q25,662,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,prior_history,NA,numeric,q75,1186,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,cohort_end_date,NA,date,median,2020-08-14,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,cohort_end_date,NA,date,q25,2020-03-23,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,cohort_end_date,NA,date,q75,2021-09-23,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,cohort_start_date,NA,date,median,2020-03-30,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,cohort_start_date,NA,date,q25,2019-09-05,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,cohort_start_date,NA,date,q75,2021-04-14,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,7699,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,24.135552838647,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,antibacterials_systemic_m365_to_0,NA,binary,count,20717,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,antibacterials_systemic_m365_to_0,NA,binary,%,64.9456095802376,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,antidepressants_m365_to_0,NA,binary,count,10019,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,antidepressants_m365_to_0,NA,binary,%,31.4085081037023,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,antiepileptics_m365_to_0,NA,binary,count,6628,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,antiepileptics_m365_to_0,NA,binary,%,20.7780808175805,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,19907,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,62.4063450264899,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,antineoplastic_agents_m365_to_0,NA,binary,count,2824,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,antineoplastic_agents_m365_to_0,NA,binary,%,8.85294209849839,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,antithrombotics_m365_to_0,NA,binary,count,3252,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,antithrombotics_m365_to_0,NA,binary,%,10.1946769491207,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,anxiety_minf_to_0,NA,binary,count,9225,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,anxiety_minf_to_0,NA,binary,%,28.9194018621273,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,asthma_minf_to_0,NA,binary,count,4523,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,asthma_minf_to_0,NA,binary,%,14.1791278723471,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,beta_blocking_agents_m365_to_0,NA,binary,count,5727,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,beta_blocking_agents_m365_to_0,NA,binary,%,17.95354086335,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,calicum_channel_blockers_m365_to_0,NA,binary,count,4520,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,calicum_channel_blockers_m365_to_0,NA,binary,%,14.1697231888147,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,chronic_kidney_disease_minf_to_0,NA,binary,count,2828,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,chronic_kidney_disease_minf_to_0,NA,binary,%,8.86548167654158,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,chronic_liver_disease_minf_to_0,NA,binary,count,2828,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,chronic_liver_disease_minf_to_0,NA,binary,%,8.86548167654158,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,copd_minf_to_0,NA,binary,count,1848,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,copd_minf_to_0,NA,binary,%,5.79328505595787,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,covid_minf_to_0,NA,binary,count,5378,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,covid_minf_to_0,NA,binary,%,16.8594626790808,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,dementia_minf_to_0,NA,binary,count,319,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,dementia_minf_to_0,NA,binary,%,1.00003134894511,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,depressive_disorder_minf_to_0,NA,binary,count,6822,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,depressive_disorder_minf_to_0,NA,binary,%,21.3862503526756,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,diabetes_minf_to_0,NA,binary,count,4126,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,diabetes_minf_to_0,NA,binary,%,12.9345747515596,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,diuretics_m365_to_0,NA,binary,count,5234,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,diuretics_m365_to_0,NA,binary,%,16.4080378695257,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,drugs_acid_related_disorder_m365_to_0,NA,binary,count,8080,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,drugs_acid_related_disorder_m365_to_0,NA,binary,%,25.3299476472617,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,8918,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,27.9569892473118,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,drugs_used_in_diabetes_m365_to_0,NA,binary,count,3683,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,drugs_used_in_diabetes_m365_to_0,NA,binary,%,11.5458164832753,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,gerd_minf_to_0,NA,binary,count,8367,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,gerd_minf_to_0,NA,binary,%,26.2296623718612,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,heart_failure_minf_to_0,NA,binary,count,1347,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,heart_failure_minf_to_0,NA,binary,%,4.22270290604721,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,hiv_minf_to_0,NA,binary,count,43,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,hiv_minf_to_0,NA,binary,%,0.134800463964388,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,2784,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,8.7275463180664,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,hypertension_minf_to_0,NA,binary,count,12989,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,hypertension_minf_to_0,NA,binary,%,40.7191448007775,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,hypothyroidism_minf_to_0,NA,binary,count,6420,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,hypothyroidism_minf_to_0,NA,binary,%,20.1260227593341,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,immunosupressants_m365_to_0,NA,binary,count,3359,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,immunosupressants_m365_to_0,NA,binary,%,10.5301106617762,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,infertility_minf_to_0,NA,binary,count,238,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,infertility_minf_to_0,NA,binary,%,0.746104893570331,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,inflammatory_bowel_disease_minf_to_0,NA,binary,count,517,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,inflammatory_bowel_disease_minf_to_0,NA,binary,%,1.62074046208345,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,lipid_modifying_agents_m365_to_0,NA,binary,count,8070,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,lipid_modifying_agents_m365_to_0,NA,binary,%,25.2985987021537,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,malaria_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,malaria_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,malignant_neoplastic_disease_minf_to_0,NA,binary,count,3774,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,malignant_neoplastic_disease_minf_to_0,NA,binary,%,11.8310918837581,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,myocardial_infarction_minf_to_0,NA,binary,count,377,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,myocardial_infarction_minf_to_0,NA,binary,%,1.18185523057149,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,opioids_m365_to_0,NA,binary,count,7914,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,opioids_m365_to_0,NA,binary,%,24.8095551584689,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,osteoporosis_minf_to_0,NA,binary,count,2278,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,osteoporosis_minf_to_0,NA,binary,%,7.14128969560174,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,pneumonia_minf_to_0,NA,binary,count,1909,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,pneumonia_minf_to_0,NA,binary,%,5.98451362111665,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,psycholeptics_m365_to_0,NA,binary,count,9038,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,psycholeptics_m365_to_0,NA,binary,%,28.3331765886078,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,psychostimulants_m365_to_0,NA,binary,count,1589,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,psychostimulants_m365_to_0,NA,binary,%,4.98134737766074,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,rheumatoid_arthritis_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,rheumatoid_arthritis_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,stroke_minf_to_0,NA,binary,count,634,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,stroke_minf_to_0,NA,binary,%,1.98752311984702,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,venous_thromboembolism_minf_to_0,NA,binary,count,854,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,venous_thromboembolism_minf_to_0,NA,binary,%,2.67719991222295,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age_group,0 to 19,categorical,count,671,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age_group,0 to 19,categorical,%,2.10351421674661,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age_group,20 to 39,categorical,count,5612,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age_group,20 to 39,categorical,%,17.593027994608,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age_group,40 to 59,categorical,count,14008,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age_group,40 to 59,categorical,%,43.9136023072824,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age_group,60 to 79,categorical,count,10152,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age_group,60 to 79,categorical,%,31.8254490736387,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age_group,80 to 150,categorical,count,1456,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,age_group,80 to 150,categorical,%,4.56440640772438,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,indication,none,categorical,count,31899,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,indication,none,categorical,%,100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,indication,rheumatoid_arthritis,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,indication,rheumatoid_arthritis,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,indication,covid,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,indication,covid,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,indication,multiple,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,indication,multiple,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,indication,malaria,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,indication,malaria,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,sex,Female,categorical,count,23136,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,sex,Female,categorical,%,72.5289194018621,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,sex,Male,categorical,count,8763,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,sex,Male,categorical,%,27.4710805981379,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,window,after_fda_retraction,categorical,count,14163,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,window,after_fda_retraction,categorical,%,44.3995109564563,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,window,before_pandemic,categorical,count,10269,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,window,before_pandemic,categorical,%,32.1922317314022,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,window,during_hcq_use_for_covid,categorical,count,7467,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,none,window,during_hcq_use_for_covid,categorical,%,23.4082573121414,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,number subjects,NA,NA,count,15039,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,number records,NA,NA,count,15039,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age,NA,numeric,median,61,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age,NA,numeric,q25,51,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age,NA,numeric,q75,70,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,future_observation,NA,numeric,median,420,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,future_observation,NA,numeric,q25,180,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,future_observation,NA,numeric,q75,771,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,prior_history,NA,numeric,median,767,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,prior_history,NA,numeric,q25,639,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,prior_history,NA,numeric,q75,1144,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,cohort_end_date,NA,date,median,2020-10-27,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,cohort_end_date,NA,date,q25,2019-11-11,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,cohort_end_date,NA,date,q75,2021-12-20,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,cohort_start_date,NA,date,median,2020-03-15,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,cohort_start_date,NA,date,q25,2019-03-13,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,cohort_start_date,NA,date,q75,2021-03-08,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,4915,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,32.6816942615865,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,antibacterials_systemic_m365_to_0,NA,binary,count,8674,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,antibacterials_systemic_m365_to_0,NA,binary,%,57.6767072278742,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,antidepressants_m365_to_0,NA,binary,count,5629,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,antidepressants_m365_to_0,NA,binary,%,37.4293503557417,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,antiepileptics_m365_to_0,NA,binary,count,4122,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,antiepileptics_m365_to_0,NA,binary,%,27.408737283064,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,11626,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,77.3056719196755,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,antineoplastic_agents_m365_to_0,NA,binary,count,5521,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,antineoplastic_agents_m365_to_0,NA,binary,%,36.7112175011636,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,antithrombotics_m365_to_0,NA,binary,count,2082,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,antithrombotics_m365_to_0,NA,binary,%,13.8440055854778,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,anxiety_minf_to_0,NA,binary,count,4505,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,anxiety_minf_to_0,NA,binary,%,29.955449165503,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,asthma_minf_to_0,NA,binary,count,2580,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,asthma_minf_to_0,NA,binary,%,17.1553959704768,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,beta_blocking_agents_m365_to_0,NA,binary,count,3662,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,beta_blocking_agents_m365_to_0,NA,binary,%,24.350023272824,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,calicum_channel_blockers_m365_to_0,NA,binary,count,2856,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,calicum_channel_blockers_m365_to_0,NA,binary,%,18.9906243766208,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,chronic_kidney_disease_minf_to_0,NA,binary,count,1877,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,chronic_kidney_disease_minf_to_0,NA,binary,%,12.480883037436,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,chronic_liver_disease_minf_to_0,NA,binary,count,1877,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,chronic_liver_disease_minf_to_0,NA,binary,%,12.480883037436,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,copd_minf_to_0,NA,binary,count,1880,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,copd_minf_to_0,NA,binary,%,12.5008311722854,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,covid_minf_to_0,NA,binary,count,2194,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,covid_minf_to_0,NA,binary,%,14.5887359531884,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,dementia_minf_to_0,NA,binary,count,282,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,dementia_minf_to_0,NA,binary,%,1.87512467584281,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,depressive_disorder_minf_to_0,NA,binary,count,3972,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,depressive_disorder_minf_to_0,NA,binary,%,26.4113305405945,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,diabetes_minf_to_0,NA,binary,count,2808,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,diabetes_minf_to_0,NA,binary,%,18.6714542190305,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,diuretics_m365_to_0,NA,binary,count,3493,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,diuretics_m365_to_0,NA,binary,%,23.2262783429749,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,drugs_acid_related_disorder_m365_to_0,NA,binary,count,5041,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,drugs_acid_related_disorder_m365_to_0,NA,binary,%,33.519515925261,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,4652,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,30.9329077731232,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,drugs_used_in_diabetes_m365_to_0,NA,binary,count,2095,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,drugs_used_in_diabetes_m365_to_0,NA,binary,%,13.9304475031585,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,gerd_minf_to_0,NA,binary,count,5130,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,gerd_minf_to_0,NA,binary,%,34.1113105924596,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,heart_failure_minf_to_0,NA,binary,count,1135,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,heart_failure_minf_to_0,NA,binary,%,7.54704435135315,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,hiv_minf_to_0,NA,binary,count,14,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,hiv_minf_to_0,NA,binary,%,0.0930912959638274,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,905,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,6.01768734623313,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,hypertension_minf_to_0,NA,binary,count,8545,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,hypertension_minf_to_0,NA,binary,%,56.8189374293504,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,hypothyroidism_minf_to_0,NA,binary,count,3523,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,hypothyroidism_minf_to_0,NA,binary,%,23.4257596914688,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,immunosupressants_m365_to_0,NA,binary,count,7106,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,immunosupressants_m365_to_0,NA,binary,%,47.2504820799255,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,infertility_minf_to_0,NA,binary,count,52,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,infertility_minf_to_0,NA,binary,%,0.345767670722787,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,inflammatory_bowel_disease_minf_to_0,NA,binary,count,247,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,inflammatory_bowel_disease_minf_to_0,NA,binary,%,1.64239643593324,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,lipid_modifying_agents_m365_to_0,NA,binary,count,5060,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,lipid_modifying_agents_m365_to_0,NA,binary,%,33.6458541126405,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,malaria_minf_to_0,NA,binary,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,malaria_minf_to_0,NA,binary,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,malignant_neoplastic_disease_minf_to_0,NA,binary,count,2227,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,malignant_neoplastic_disease_minf_to_0,NA,binary,%,14.8081654365317,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,myocardial_infarction_minf_to_0,NA,binary,count,299,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,myocardial_infarction_minf_to_0,NA,binary,%,1.98816410665603,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,opioids_m365_to_0,NA,binary,count,5031,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,opioids_m365_to_0,NA,binary,%,33.4530221424297,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,osteoporosis_minf_to_0,NA,binary,count,2500,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,osteoporosis_minf_to_0,NA,binary,%,16.6234457078263,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,pneumonia_minf_to_0,NA,binary,count,1430,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,pneumonia_minf_to_0,NA,binary,%,9.50861094487665,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,psycholeptics_m365_to_0,NA,binary,count,4486,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,psycholeptics_m365_to_0,NA,binary,%,29.8291109781235,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,psychostimulants_m365_to_0,NA,binary,count,444,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,psychostimulants_m365_to_0,NA,binary,%,2.95232395770995,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,rheumatoid_arthritis_minf_to_0,NA,binary,count,15028,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,rheumatoid_arthritis_minf_to_0,NA,binary,%,99.9268568388856,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,stroke_minf_to_0,NA,binary,count,420,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,stroke_minf_to_0,NA,binary,%,2.79273887891482,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,venous_thromboembolism_minf_to_0,NA,binary,count,541,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,venous_thromboembolism_minf_to_0,NA,binary,%,3.59731365117362,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age_group,0 to 19,categorical,count,57,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age_group,0 to 19,categorical,%,0.37901456213844,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age_group,20 to 39,categorical,count,1357,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age_group,20 to 39,categorical,%,9.02320633020813,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age_group,40 to 59,categorical,count,5457,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age_group,40 to 59,categorical,%,36.2856572910433,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age_group,60 to 79,categorical,count,6849,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age_group,60 to 79,categorical,%,45.541591861161,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age_group,80 to 150,categorical,count,1319,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,age_group,80 to 150,categorical,%,8.77052995544916,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,indication,rheumatoid_arthritis,categorical,count,15039,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,indication,rheumatoid_arthritis,categorical,%,100,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,indication,none,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,indication,none,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,indication,covid,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,indication,covid,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,indication,multiple,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,indication,multiple,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,indication,malaria,categorical,count,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,indication,malaria,categorical,%,0,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,sex,Female,categorical,count,12070,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,sex,Female,categorical,%,80.2579958773855,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,sex,Male,categorical,count,2969,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,sex,Male,categorical,%,19.7420041226145,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,window,after_fda_retraction,categorical,count,6363,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,window,after_fda_retraction,categorical,%,42.3099940155595,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,window,before_pandemic,categorical,count,6972,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,window,before_pandemic,categorical,%,46.359465389986,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,window,during_hcq_use_for_covid,categorical,count,1704,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Indication,rheumatoid_arthritis,window,during_hcq_use_for_covid,categorical,%,11.3305405944544,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,number subjects,NA,NA,count,49646,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,number records,NA,NA,count,49646,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age,NA,numeric,median,56,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age,NA,numeric,q25,45,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age,NA,numeric,q75,66,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,future_observation,NA,numeric,median,395,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,future_observation,NA,numeric,q25,164,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,future_observation,NA,numeric,q75,736,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,prior_history,NA,numeric,median,852,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,prior_history,NA,numeric,q25,659,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,prior_history,NA,numeric,q75,1191,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,cohort_end_date,NA,date,median,2020-10-01,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,cohort_end_date,NA,date,q25,2020-03-05,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,cohort_end_date,NA,date,q75,2021-10-21,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,cohort_start_date,NA,date,median,2020-04-08,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,cohort_start_date,NA,date,q25,2019-07-23,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,cohort_start_date,NA,date,q75,2021-04-23,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,count,13369,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,agents_acting_on_renin_angiotensin_system_m365_to_0,NA,binary,%,26.9286548765258,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,antibacterials_systemic_m365_to_0,NA,binary,count,31722,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,antibacterials_systemic_m365_to_0,NA,binary,%,63.896386415824,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,antidepressants_m365_to_0,NA,binary,count,16364,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,antidepressants_m365_to_0,NA,binary,%,32.9613664746405,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,antiepileptics_m365_to_0,NA,binary,count,11177,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,antiepileptics_m365_to_0,NA,binary,%,22.5133948354349,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,count,33501,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,antiinflammatory_antirheumatic_agents_m365_to_0,NA,binary,%,67.4797566772751,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,antineoplastic_agents_m365_to_0,NA,binary,count,8484,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,antineoplastic_agents_m365_to_0,NA,binary,%,17.0889900495508,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,antithrombotics_m365_to_0,NA,binary,count,5649,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,antithrombotics_m365_to_0,NA,binary,%,11.3785602062603,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,anxiety_minf_to_0,NA,binary,count,14518,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,anxiety_minf_to_0,NA,binary,%,29.2430407283568,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,asthma_minf_to_0,NA,binary,count,7514,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,asthma_minf_to_0,NA,binary,%,15.1351569109294,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,beta_blocking_agents_m365_to_0,NA,binary,count,9904,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,beta_blocking_agents_m365_to_0,NA,binary,%,19.9492406236152,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,calicum_channel_blockers_m365_to_0,NA,binary,count,7768,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,calicum_channel_blockers_m365_to_0,NA,binary,%,15.6467791967127,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,chronic_kidney_disease_minf_to_0,NA,binary,count,4940,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,chronic_kidney_disease_minf_to_0,NA,binary,%,9.95044918019579,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,chronic_liver_disease_minf_to_0,NA,binary,count,4940,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,chronic_liver_disease_minf_to_0,NA,binary,%,9.95044918019579,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,copd_minf_to_0,NA,binary,count,3933,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,copd_minf_to_0,NA,binary,%,7.92208838577126,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,covid_minf_to_0,NA,binary,count,10274,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,covid_minf_to_0,NA,binary,%,20.6945171816461,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,dementia_minf_to_0,NA,binary,count,664,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,dementia_minf_to_0,NA,binary,%,1.33746928252024,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,depressive_disorder_minf_to_0,NA,binary,count,11331,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,depressive_disorder_minf_to_0,NA,binary,%,22.8235910244531,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,diabetes_minf_to_0,NA,binary,count,7475,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,diabetes_minf_to_0,NA,binary,%,15.056600733191,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,diuretics_m365_to_0,NA,binary,count,9149,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,diuretics_m365_to_0,NA,binary,%,18.4284735930387,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,drugs_acid_related_disorder_m365_to_0,NA,binary,count,13808,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,drugs_acid_related_disorder_m365_to_0,NA,binary,%,27.8129154413246,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,count,14795,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,drugs_for_obstructive_airway_diseases_m365_to_0,NA,binary,%,29.8009910163961,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,drugs_used_in_diabetes_m365_to_0,NA,binary,count,6225,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,drugs_used_in_diabetes_m365_to_0,NA,binary,%,12.5387745236273,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,gerd_minf_to_0,NA,binary,count,14289,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,gerd_minf_to_0,NA,binary,%,28.7817749667647,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,heart_failure_minf_to_0,NA,binary,count,2637,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,heart_failure_minf_to_0,NA,binary,%,5.3116061716956,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,hiv_minf_to_0,NA,binary,count,62,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,hiv_minf_to_0,NA,binary,%,0.12488417999436,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,hormonal_contraceptices_systemic_m365_to_0,NA,binary,count,3854,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,hormonal_contraceptices_systemic_m365_to_0,NA,binary,%,7.76296176932683,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,hypertension_minf_to_0,NA,binary,count,22861,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,hypertension_minf_to_0,NA,binary,%,46.0480199814688,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,hypothyroidism_minf_to_0,NA,binary,count,10389,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,hypothyroidism_minf_to_0,NA,binary,%,20.9261571929259,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,immunosupressants_m365_to_0,NA,binary,count,10602,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,immunosupressants_m365_to_0,NA,binary,%,21.3551947790356,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,infertility_minf_to_0,NA,binary,count,299,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,infertility_minf_to_0,NA,binary,%,0.60226402932764,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,inflammatory_bowel_disease_minf_to_0,NA,binary,count,798,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,inflammatory_bowel_disease_minf_to_0,NA,binary,%,1.60738025218547,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,lipid_modifying_agents_m365_to_0,NA,binary,count,13946,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,lipid_modifying_agents_m365_to_0,NA,binary,%,28.0908834548604,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,malaria_minf_to_0,NA,binary,count,9,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,malaria_minf_to_0,NA,binary,%,0.0181283487088587,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,malignant_neoplastic_disease_minf_to_0,NA,binary,count,6301,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,malignant_neoplastic_disease_minf_to_0,NA,binary,%,12.6918583571688,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,myocardial_infarction_minf_to_0,NA,binary,count,734,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,myocardial_infarction_minf_to_0,NA,binary,%,1.47846755025581,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,number_visits,NA,numeric,median,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,number_visits,NA,numeric,q25,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,number_visits,NA,numeric,q75,1,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,opioids_m365_to_0,NA,binary,count,13578,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,opioids_m365_to_0,NA,binary,%,27.3496354187649,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,osteoporosis_minf_to_0,NA,binary,count,4898,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,osteoporosis_minf_to_0,NA,binary,%,9.86585021955445,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,pneumonia_minf_to_0,NA,binary,count,3961,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,pneumonia_minf_to_0,NA,binary,%,7.97848769286549,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,psycholeptics_m365_to_0,NA,binary,count,14195,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,psycholeptics_m365_to_0,NA,binary,%,28.5924344358055,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,psychostimulants_m365_to_0,NA,binary,count,2140,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,psychostimulants_m365_to_0,NA,binary,%,4.31051847077307,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,rheumatoid_arthritis_minf_to_0,NA,binary,count,15180,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,rheumatoid_arthritis_minf_to_0,NA,binary,%,30.5764814889417,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,stroke_minf_to_0,NA,binary,count,1118,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,stroke_minf_to_0,NA,binary,%,2.25194376183378,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,venous_thromboembolism_minf_to_0,NA,binary,count,1467,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,venous_thromboembolism_minf_to_0,NA,binary,%,2.95492083954397,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age_group,0 to 19,categorical,count,785,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age_group,0 to 19,categorical,%,1.58119485960601,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age_group,20 to 39,categorical,count,7438,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age_group,20 to 39,categorical,%,14.9820730773879,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age_group,40 to 59,categorical,count,20694,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age_group,40 to 59,categorical,%,41.6831164645692,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age_group,60 to 79,categorical,count,17792,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age_group,60 to 79,categorical,%,35.837731136446,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age_group,80 to 150,categorical,count,2937,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,age_group,80 to 150,categorical,%,5.9158844619909,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,indication,covid,categorical,count,2549,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,indication,covid,categorical,%,5.13435120654232,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,indication,malaria,categorical,count,7,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,indication,malaria,categorical,%,0.0140998267735568,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,indication,multiple,categorical,count,152,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,indication,multiple,categorical,%,0.306167667082947,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,indication,none,categorical,count,31899,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,indication,none,categorical,%,64.2529106070983,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,indication,rheumatoid_arthritis,categorical,count,15039,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,indication,rheumatoid_arthritis,categorical,%,30.2924706925029,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,sex,Female,categorical,count,36664,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,sex,Female,categorical,%,73.8508641179551,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,sex,Male,categorical,count,12982,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,sex,Male,categorical,%,26.1491358820449,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,window,after_fda_retraction,categorical,count,22836,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,window,after_fda_retraction,categorical,%,45.9976634572775,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,window,before_pandemic,categorical,count,17245,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,window,before_pandemic,categorical,%,34.735930387141,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,window,during_hcq_use_for_covid,categorical,count,9565,PHARMETRICS
Cohort name,new_users_hydroxychloroquine,Overall,Overall,window,during_hcq_use_for_covid,categorical,%,19.2664061555815,PHARMETRICS
